{"content":"<li class=\"n-box-item date-title\" data-end=\"1561694399\" data-start=\"1561608000\" data-txt=\"Monday, December 23, 2019\">Thursday, June 27, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3474491\" data-ts=\"1561672124\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CALA\" target=\"_blank\">CALA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474491-calitheraplus-4_5-amid-200k-purchase-ceos-trust\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Calithera +4.5% amid $200K purchase by CEO&#39;s trust</a></h4><ul>   <li>Calithera Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CALA' title='Calithera Biosciences, Inc.'>CALA</a>) is <font color=\"green\">up 4.5%</font> after hours following a <a href=\"https://seekingalpha.com/filing/4547135\" target=\"_blank\">filing disclosing a purchase</a> of just over $200,000 worth of stock by the CEO's family trust.</li>    <li>CEO Susan Molineaux and Christopher Molineaux, the company's senior VP of Development, disclosed the purchase by the Molineaux Family Trust.</li>    <li>The Trust bought 51,600 shares at an average price of $3.88 on Tuesday, leaving it with beneficial ownership of 457,188 shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474491\" data-linked=\"Calithera +4.5% amid $200K purchase by CEO&#39;s trust\" data-tweet=\"$CALA - Calithera +4.5% amid $200K purchase by CEO&#39;s trust https://seekingalpha.com/news/3474491-calitheraplus-4_5-amid-200k-purchase-ceos-trust?source=tweet\" data-url=\"https://seekingalpha.com/news/3474491-calitheraplus-4_5-amid-200k-purchase-ceos-trust\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474488\" data-ts=\"1561671890\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474488-camp-nktr-sogo-and-mgi-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CAMP, NKTR, SOGO and MGI among notable after hour movers</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/CAMP' title='CalAmp Corp.'>CAMP</a> <font color=\"green\">+23.2%</font>. <a href='https://seekingalpha.com/symbol/PRGS' title='Progress Software Corporation'>PRGS</a> <font color=\"green\">+15.8%</font>. <a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a> <font color=\"green\">+3.1%</font>. <a href='https://seekingalpha.com/symbol/CHMA' title='Chiasma, Inc.'>CHMA</a> <font color=\"green\">+2.6%</font>. <a href='https://seekingalpha.com/symbol/ADPT' title='Adaptive Biotechnologies'>ADPT</a> <font color=\"green\">+2.2%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/SGH' title='SMART Global Holdings, Inc.'>SGH</a> <font color=\"red\">-12.9%</font>. <a href='https://seekingalpha.com/symbol/HCM' title='Hutchison China MediTech Limited'>HCM</a> <font color=\"red\">-8.1%</font>. <a href='https://seekingalpha.com/symbol/CLCT' title='Collectors Universe, Inc.'>CLCT</a> <font color=\"red\">-4.1%</font>. <a href='https://seekingalpha.com/symbol/SOGO' title='Sogou Inc.'>SOGO</a> <font color=\"red\">-3.7%</font>. <a href='https://seekingalpha.com/symbol/NKTR' title='Nektar Therapeutics'>NKTR</a> <font color=\"red\">-3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474488\" data-linked=\"CAMP, NKTR, SOGO and MGI among notable after hour movers\" data-tweet=\"$CAMP $PRGS $MGI - CAMP, NKTR, SOGO and MGI among notable after hour movers https://seekingalpha.com/news/3474488-camp-nktr-sogo-and-mgi-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3474488-camp-nktr-sogo-and-mgi-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474486\" data-ts=\"1561671458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JPM\" target=\"_blank\">JPM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474486-jpmorganplus-1_5-on-plan-to-boost-dividend-stock-buybacks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan +1.5% on plan to boost dividend, stock buybacks</a></h4><ul><li>JPMorgan Chase (NYSE:<a href='https://seekingalpha.com/symbol/JPM' title='JPMorgan Chase & Co.'>JPM</a>) <font color=\"green\">rises 1.5%</font> in after-hours trading after unveiling its<a href=\"https://seekingalpha.com/pr/17558678-jpmorgan-chase-announces-2019-ccar-results\" target=\"_blank\"> capital program</a>.</li><li>After the Federal Reserve Board didn't object to its capital plan, JPMorgan said its board intends to boost its quarter common stock dividend to 90 cents per share from 80 cents, effective Q3 2019, and authorizes gross common equity repurchases of up to $29.4B between July 1, 2019 and June 30, 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474486\" data-linked=\"JPMorgan +1.5% on plan to boost dividend, stock buybacks\" data-tweet=\"$JPM - JPMorgan +1.5% on plan to boost dividend, stock buybacks https://seekingalpha.com/news/3474486-jpmorganplus-1_5-on-plan-to-boost-dividend-stock-buybacks?source=tweet\" data-url=\"https://seekingalpha.com/news/3474486-jpmorganplus-1_5-on-plan-to-boost-dividend-stock-buybacks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474474\" data-ts=\"1561669116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDMO\" target=\"_blank\">CDMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474474-avid-bioservices-eps-beats-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avid Bioservices EPS beats by $0.01, beats on revenue</a></h4><ul><li>Avid Bioservices (NASDAQ:<a href='https://seekingalpha.com/symbol/CDMO' title='Avid Bioservices, Inc.'>CDMO</a>): Q4 GAAP EPS of -$0.02 <font color=\"green\">beats by $0.01</font>.</li><li>Revenue of $17.06M (+145.8% Y/Y) <font color=\"green\">beats by $1.41M</font>.</li><li>Shares <font color=\"green\">+1.5%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17558583-avid-bioservices-reports-financial-results-quarter-fiscal-year-ended-april-30-2019-recent\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3474474\" data-linked=\"Avid Bioservices EPS beats by $0.01, beats on revenue\" data-tweet=\"$CDMO - Avid Bioservices EPS beats by $0.01, beats on revenue https://seekingalpha.com/news/3474474-avid-bioservices-eps-beats-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3474474-avid-bioservices-eps-beats-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474473\" data-ts=\"1561669071\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474473-jony-ive-leaving-apple\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jony Ive leaving Apple</a></h4><ul><li>Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) <a href=\"https://seekingalpha.com/pr/17558702-jony-ive-form-independent-design-company-apple-client\" target=\"_blank\">announces</a> that its Chief Design Officer will leave later this year to form an independent design company with Apple as a client. Ive has led Apple's design team since 1996.</li><li>Design team leaders Evans Hankey, VP of Industrial Design, and Alan Dye, VP of Human Interface Design, will report to COO Jeff Williams after Ive's departure.</li><li>Apple shares are <font color=\"red\">down 1.2%</font> after hours to $197.30.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474473\" data-linked=\"Jony Ive leaving Apple\" data-tweet=\"$AAPL - Jony Ive leaving Apple https://seekingalpha.com/news/3474473-jony-ive-leaving-apple?source=tweet\" data-url=\"https://seekingalpha.com/news/3474473-jony-ive-leaving-apple\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>166&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474470\" data-ts=\"1561668879\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTVT\" target=\"_blank\">VTVT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474470-mid-stage-study-underway-for-vtvs-azeliragon-in-alzheimers-and-t2d-shares-up-8-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mid-stage study underway for vTv&#39;s azeliragon in Alzheimer&#39;s and T2D; shares up 8% after hours</a></h4><ul><li>Nano cap vTv Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics Inc.'>VTVT</a>) perks up <font color=\"green\">8%</font> after hours in response to the <a href=\"https://seekingalpha.com/pr/17558643-vtv-therapeutics-initiates-phase-2-clinical-trial-evaluating-azeliragon-patients-mild\" target=\"_blank\">initiation </a>of a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03980730?spons=vtv+therapeutics&amp;phase=1&amp;rank=7\" target=\"_blank\">Phase 2 clinical trial</a> evaluating azeliragon in patients with mild Alzheimer's disease &#40;AD&#41; and type 2 diabetes (T2D).</li><li>The primary objective is the effect on AD as measured by three scales. Topline data should be available in late 2020. The estimated primary completion date is April 2023.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474470\" data-linked=\"Mid-stage study underway for vTv&#39;s azeliragon in Alzheimer&#39;s and T2D; shares up 8% after hours\" data-tweet=\"$VTVT - Mid-stage study underway for vTv&#39;s azeliragon in Alzheimer&#39;s and T2D; shares up 8% after hours https://seekingalpha.com/news/3474470-mid-stage-study-underway-for-vtvs-azeliragon-in-alzheimers-and-t2d-shares-up-8-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3474470-mid-stage-study-underway-for-vtvs-azeliragon-in-alzheimers-and-t2d-shares-up-8-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474457\" data-ts=\"1561667886\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHMA\" target=\"_blank\">CHMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474457-key-data-readout-approaches-for-chiasmas-mycapssa\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Key data readout approaches for Chiasma&#39;s Mycapssa</a></h4><ul><li>In an update to investors, Chiasma (NASDAQ:<a href='https://seekingalpha.com/symbol/CHMA' title='Chiasma, Inc.'>CHMA</a>) <a href=\"https://seekingalpha.com/pr/17558578-chiasma-provides-update-ongoing-mycapssa-phase-3-clinical-trials\" target=\"_blank\">announces </a>that topline data from the Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT03252353?spons=chiasma&amp;rank=1\" target=\"_blank\">OPTIMAL </a>study evaluating Mycapssa (octreotide) in patients with acromegaly should be released by mid-Q3.</li><li>A second Phase 3, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02685709?spons=chiasma&amp;rank=2\" target=\"_blank\">IMPOWERED</a>, is also advancing. Only 10 subjects remain active in the run-in phase. Most have been randomized into the nine-month controlled phase. Topline results should be available in H2 2020.</li><li>The company says it plans to file a U.S. marketing application later this year based on a positive outcome of OPTIMAL. If all goes well, the FDA nod could happen by mid-2020.</li><li>On another note, it will join the Russell 3000 Index effective July 1.</li><li>Shares are up <font color=\"green\">2%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474457\" data-linked=\"Key data readout approaches for Chiasma&#39;s Mycapssa\" data-tweet=\"$CHMA - Key data readout approaches for Chiasma&#39;s Mycapssa https://seekingalpha.com/news/3474457-key-data-readout-approaches-for-chiasmas-mycapssa?source=tweet\" data-url=\"https://seekingalpha.com/news/3474457-key-data-readout-approaches-for-chiasmas-mycapssa\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474450\" data-ts=\"1561667230\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRGS\" target=\"_blank\">PRGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474450-progressplus-12-after-upside-earnings-outlooks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Progress +12% after upside earnings outlooks</a></h4><ul><li>Progress Software (NASDAQ:<a href='https://seekingalpha.com/symbol/PRGS' title='Progress Software Corporation'>PRGS</a>) <font color=\"green\">+12% </font>reports <a href=\"https://seekingalpha.com/news/3474439-progress-software-eps-beats-0_08-beats-revenue\" target=\"_blank\">Q2 beats</a> with upside Q3 and FY19 earnings guidance.</li><li>The Q3 outlook has revenue of $109-112M and EPS of $0.68-0.70 (consensus: $0.66).</li><li>The FY19 view has revenue of $422-428M and EPS of $2.52-2.57 (consensus: $2.51).</li><li>Earnings call starts at 5 PM ET with a webcast <a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.progress.com&amp;esheet=52006211&amp;newsitemid=20190627005847&amp;lan=en-US&amp;anchor=www.progress.com&amp;index=1&amp;md5=16d708cec89f63b82365c9cfa8290022\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17558603-progress-2019-second-quarter-results-exceed-guidance\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474450\" data-linked=\"Progress +12% after upside earnings outlooks\" data-tweet=\"$PRGS - Progress +12% after upside earnings outlooks https://seekingalpha.com/news/3474450-progressplus-12-after-upside-earnings-outlooks?source=tweet\" data-url=\"https://seekingalpha.com/news/3474450-progressplus-12-after-upside-earnings-outlooks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474446\" data-ts=\"1561666995\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474446-nikeminus-2-after-profit-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nike -2% after profit miss</a></h4><ul> <li>Nike (NYSE:<a href='https://seekingalpha.com/symbol/NKE' title='NIKE, Inc.'>NKE</a>) slips after reporting 4% revenue growth in FQ4 (+10% on a constant currency basis).</li> <li>Revenue growth by region: North America +7.5% to $4.2B, EMEA -0.4% to $2.46B, Greater China +16% to $1.70B, Asia Pacific &amp; Latin America -4% to $1.38B.</li> <li>Gross margin came in at 45.5% of sales vs. 44.7% a year ago and 45.6% consensus. Higher average selling prices, impacts from foreign currency and growth in Nike Direct helped push up the margin rate.</li> <li>Selling and administrative expenses rose 9% to $3.4B during the period.</li> <li>Guidance from management will be coming up on Nike conference call scheduled for 5:00 pm Eastern.</li> <li>Shares of Nike are <font color=\"red\">down 1.98%</font> AH to $82.00 after rising 1.34% today into the report.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3474437-nike-eps-misses-0_04-beats-revenue\" target=\"_blank\">Nike EPS misses by $0.04, beats on revenue</a> (June 27)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474446\" data-linked=\"Nike -2% after profit miss\" data-tweet=\"$NKE - Nike -2% after profit miss https://seekingalpha.com/news/3474446-nikeminus-2-after-profit-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3474446-nikeminus-2-after-profit-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474442\" data-ts=\"1561666751\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARCT\" target=\"_blank\">ARCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474442-arcturus-lead-candidate-orphan-drug-in-u-s-for-otcd-shares-up-5-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arcturus&#39; lead candidate an Orphan Drug in U.S. for OTCD; shares up 5% after hours</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17558556-arcturus-therapeutics-receives-orphan-drug-designation-u-s-fda-arctminus-810-treatment\" target=\"_blank\">designates </a>Arcturus Therapeutics' (NASDAQ:<a href='https://seekingalpha.com/symbol/ARCT' title='Arcturus Therapeutics Holdings Inc'>ARCT</a>) lead candidate ARCT-810 an Orphan Drug for the treatment of <a href=\"https://ghr.nlm.nih.gov/condition/ornithine-transcarbamylase-deficiency#statistics\" target=\"_blank\">ornithine transcarbamylase deficiency</a> &#40;OTCD&#41;, a relatively rare urea cycle disorder in which ammonia accumulates in the body leading to nervous system damage.</li><li>ARCT-810 is an mRNA construct designed to deliver OTC to liver cells.</li><li>The company plans to file an IND in Q1 2020.</li><li>Among the benefits of Orphan Drug status in the U.S. is a seven-year period of market exclusivity for the indication, if approved.</li><li>Shares are up <font color=\"green\">5%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474442\" data-linked=\"Arcturus&#39; lead candidate an Orphan Drug in U.S. for OTCD; shares up 5% after hours\" data-tweet=\"$ARCT - Arcturus&#39; lead candidate an Orphan Drug in U.S. for OTCD; shares up 5% after hours https://seekingalpha.com/news/3474442-arcturus-lead-candidate-orphan-drug-in-u-s-for-otcd-shares-up-5-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3474442-arcturus-lead-candidate-orphan-drug-in-u-s-for-otcd-shares-up-5-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474440\" data-ts=\"1561666711\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAMP\" target=\"_blank\">CAMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474440-calampplus-7_8-q1-profits-top-highest-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CalAmp +7.8% as Q1 profits top highest estimates</a></h4><ul>   <li>CalAmp (NASDAQ:<a href='https://seekingalpha.com/symbol/CAMP' title='CalAmp Corp.'>CAMP</a>) is <font color=\"green\">up 7.8%</font> postmarket after topping high estimates for profits and posting a smaller-than-expected revenue decline in its fiscal Q1 report.</li>    <li>Telematics Systems revenue dropped as expected, but Software and Subscriptions Services rose 38% to a record.</li>    <li>Gross margin was flat at 40%, and while the company swung to a loss on a GAAP basis amid one-time legal expenses, adjusted net income fell to $4.2M from $10.5M.</li>    <li>Subscribers increased to surpass 1.2M, helped by recent acquisitions of Tracker, Car Track (LoJack Mexico) and Synovia Solutions.</li>    <li>Revenue by segment: Telematics Systems, $63.6M; Software &amp; Subscription Services, $25.5M (up 38%).</li>    <li>Operating cash outflow was $5.6M.</li>    <li>For Q2, it sees \"revenue momentum across our SaaS businesses combined with an increase in MRM Telematics sales due to customer LTE transitions,\" says CEO Michael Burdiek.</li>    <li>It's guiding to revenues of $89.5M-$94.5M (vs. consensus for $91.2M), EBITDA of $7.5M-$11.5M, and EPS of $0.08-$0.14 (slightly below consensus for $0.16).</li>    <li><a href=\"https://event.on24.com/wcc/r/2017208/E02DE82C28AD123E30703534EF00305F\" target=\"_blank\">Conference call</a> to come at 4:30 p.m. ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3474426-calamp-eps-beats-0_03-beats-revenue\" target=\"_blank\">CalAmp EPS beats by $0.03, beats on revenue</a> (Jun. 27 2019)</li>    <li><a href=\"https://seekingalpha.com/pr/17558567-calamp-reports-fiscal-2020-first-quarter-financial-results\" target=\"_blank\">Press release</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3474440\" data-linked=\"CalAmp +7.8% as Q1 profits top highest estimates\" data-tweet=\"$CAMP - CalAmp +7.8% as Q1 profits top highest estimates https://seekingalpha.com/news/3474440-calampplus-7_8-q1-profits-top-highest-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3474440-calampplus-7_8-q1-profits-top-highest-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474439\" data-ts=\"1561666689\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRGS\" target=\"_blank\">PRGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474439-progress-software-eps-beats-0_08-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Progress Software EPS beats by $0.08, beats on revenue</a></h4><ul><li>Progress Software (NASDAQ:<a href='https://seekingalpha.com/symbol/PRGS' title='Progress Software Corporation'>PRGS</a>): Q2 Non-GAAP EPS of $0.65 <font color=\"green\">beats by $0.08</font>; GAAP EPS of $0.18 <font color=\"green\">beats by $0.01</font>.</li><li>Revenue of $103.47M (+11.3% Y/Y) <font color=\"green\">beats by $5.27M</font>.</li><li>Shares <font color=\"green\">+7.06%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17558603-progress-2019-second-quarter-results-exceed-guidance\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3474439\" data-linked=\"Progress Software EPS beats by $0.08, beats on revenue\" data-tweet=\"$PRGS - Progress Software EPS beats by $0.08, beats on revenue https://seekingalpha.com/news/3474439-progress-software-eps-beats-0_08-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3474439-progress-software-eps-beats-0_08-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474434\" data-ts=\"1561666499\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGH\" target=\"_blank\">SGH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474434-smart-globalminus-13_4-on-weak-q4-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Smart Global -13.4% on weak Q4 outlook</a></h4><ul><li>Smart Global (NASDAQ:<a href='https://seekingalpha.com/symbol/SGH' title='SMART Global Holdings, Inc.'>SGH</a>) plunges <font color=\"red\">13.4%</font> after <a href=\"https://seekingalpha.com/news/3474429-smart-global-eps-misses-0_03-misses-revenue\" target=\"_blank\">Q3 results</a> that missed earnings and revenue estimates with a 30% Y/Y decline in revenue.</li><li>The downside Q4 outlook has revenue of $270-280M (consensus: ), EPS of $0.55 to $0.65 (consensus: ), and gross margin of 19% to 21%. SGH does expect \"significantly better\" earnings and revenue starting at the end of Q4 due to improvements in Specialty Memory and strength in Specialty Computer.</li><li>Earnings call starts at 4:30 PM ET with a webcast <a href=\"http://www.smartgh.com/\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17558581-smart-global-holdings-reports-third-quarter-fiscal-2019-financial-results\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474434\" data-linked=\"Smart Global -13.4% on weak Q4 outlook\" data-tweet=\"$SGH - Smart Global -13.4% on weak Q4 outlook https://seekingalpha.com/news/3474434-smart-globalminus-13_4-on-weak-q4-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3474434-smart-globalminus-13_4-on-weak-q4-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474418\" data-ts=\"1561665188\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFI\" target=\"_blank\">INFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474418-oppenheimer-likes-infinity-pharma-sees-74-upside-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer likes Infinity Pharma, sees 74% upside; shares up 4%</a></h4><ul><li>Oppenheimer initiates coverage on thinly traded nano cap Infinity Pharmaceuticals (<a href='https://seekingalpha.com/symbol/INFI' title='Infinity Pharmaceuticals, Inc.'>INFI</a> <font color=\"green\">+3.6%</font>) with an Outperform rating and $3 (74% upside) price target.</li><li>Again, the valuation model is based on events far in the future:</li><li>Positive data from the Phase 1 MARIO-1 study showing that IPI-549 down-regulates myeloid-derived suppressor cells in checkpoint inhibitor-resistant patients.</li><li>Expectation that the Phase 1/1b MARIO-275 study will demonstrate proof-of-concept by H2 2020.</li><li>Peak sales of at least $535M (10+ years out).</li></ul><div class=\"tiny-share-widget\" data-id=\"3474418\" data-linked=\"Oppenheimer likes Infinity Pharma, sees 74% upside; shares up 4%\" data-tweet=\"$INFI - Oppenheimer likes Infinity Pharma, sees 74% upside; shares up 4% https://seekingalpha.com/news/3474418-oppenheimer-likes-infinity-pharma-sees-74-upside-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3474418-oppenheimer-likes-infinity-pharma-sees-74-upside-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474416\" data-ts=\"1561664638\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474416-latest-bill-to-settle-c-band-issue-faces-struggle-analyst\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Latest bill to settle C-band issue faces struggle - analyst</a></h4><ul>   <li>A draft bill designed to settle a stalled effort to clear and monetize former satellite spectrum for use by wireless carriers in 5G development is likely \"dead on arrival,\" Height Capital Markets says.</li>    <li>The bill from California Rep. Doris Matsui looks to offer incentives to clear more than 200 MHz of spectrum, but does so in a way similar to those \"vehemently\" opposed by content companies and broadcasters before, Height says, and it has no GOP co-sponsors, signifying a lack of necessary support in Congress.</li>    <li>But Height still expects the FCC to move forward with a draft order providing for an auction format for the C-Band Alliance, working to monetize those airwaves. (h/t Bloomberg)</li>    <li>The C-Band push is being led by Intelsat (<a href=\"http://seekingalpha.com/symbol/I\" target=\"_blank\">I</a> <font color=\"green\">+0.2%</font>) and SES (<a href=\"http://seekingalpha.com/symbol/SGBAF\" target=\"_blank\">SGBAF</a> <font color=\"red\">-1.3%</font>), along with Intel (<a href=\"http://seekingalpha.com/symbol/INTC\" target=\"_blank\">INTC</a> <font color=\"red\">-1.6%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474416\" data-linked=\"Latest bill to settle C-band issue faces struggle - analyst\" data-tweet=\"$I $SGBAF $INTC - Latest bill to settle C-band issue faces struggle - analyst https://seekingalpha.com/news/3474416-latest-bill-to-settle-c-band-issue-faces-struggle-analyst?source=tweet\" data-url=\"https://seekingalpha.com/news/3474416-latest-bill-to-settle-c-band-issue-faces-struggle-analyst\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474419\" data-ts=\"1561664600\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474419-boeing-may-need-three-months-to-fix-max-issue-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing may need three months to fix MAX issue - report</a></h4><ul><li>Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color=\"red\">-2.8%</font>) skids to its lows of the day following headlines that the company will need an additional three months to fix the latest 737 MAX issue.</li><li>Shares already were lower after the Federal Aviation Administration said it <a href=\"https://seekingalpha.com/news/3474074-faa-identifies-new-potential-risk-boeing-737-max-reuters\" target=\"_blank\">found a new issue</a> with 737 MAX software that could further delay the plane's return to service.</li><li><strong>Update:</strong> A Boeing official estimates the company will complete the latest 737 MAX software update by September, meaning the plane likely would <a href=\"https://www.reuters.com/article/us-ethiopia-airplane-crash/boeing-thinks-it-will-complete-it-software-update-for-737-max-by-september-official-idUSKCN1TS31K?il=0\" target=\"_blank\">not resume flying until at least October</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474419\" data-linked=\"Boeing may need three months to fix MAX issue - report\" data-tweet=\"$BA - Boeing may need three months to fix MAX issue - report https://seekingalpha.com/news/3474419-boeing-may-need-three-months-to-fix-max-issue-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3474419-boeing-may-need-three-months-to-fix-max-issue-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474414\" data-ts=\"1561664198\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VBLT\" target=\"_blank\">VBLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474414-oppenheimer-bullish-on-vascular-biogenics-shares-up-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer bullish on Vascular Biogenics; shares up 9%</a></h4><ul><li>Thinly traded nano cap Vascular Biogenics (<a href='https://seekingalpha.com/symbol/VBLT' title='Vascular Biogenics Ltd.'>VBLT</a> <font color=\"green\">+8.7%</font>) perks up on almost 20% higher volume, albeit on turnover of only 108K shares, on the heels of new coverage at Oppenheimer who rates it Outperform with a $2 (57% upside) price target.</li><li>Before bulls get too giddy, the bullish call is based on events that will occur far in the future with expected cash flows discounted to the present:</li><li>Expectation of positive interim data from the Phase 3 OVAL study of VB-111 in platinum-resistant ovarian cancer in late Q4.</li><li>The potential for accelerated approval of VB-111 based on discussions with the FDA that may start in 2020.</li><li>Call option on market expansion of VB-111, combined with checkpoint inhibitors, and potentially for brain cancer as monotherapy (no timeline given).</li><li>Expectation that the company will partner VB-111 prior to FDA approval in H2 2023.</li><li>Expected royalties of $100M in 2028.</li><li>Expected peak sales of $250M (10+ years out).</li><li>Quant rating is <a href=\"https://seekingalpha.com/symbol/VBLT/ratings/quant-ratings\" target=\"_blank\">Neutral </a>while the Sell Side Rating is <a href=\"https://seekingalpha.com/symbol/VBLT/ratings/sell-side-ratings\" target=\"_blank\">Outperform </a>(one analyst).</li></ul><div class=\"tiny-share-widget\" data-id=\"3474414\" data-linked=\"Oppenheimer bullish on Vascular Biogenics; shares up 9%\" data-tweet=\"$VBLT - Oppenheimer bullish on Vascular Biogenics; shares up 9% https://seekingalpha.com/news/3474414-oppenheimer-bullish-on-vascular-biogenics-shares-up-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3474414-oppenheimer-bullish-on-vascular-biogenics-shares-up-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474415\" data-ts=\"1561663970\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACDVF\" target=\"_blank\">ACDVF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474415-transats-board-accepts-air-canada-buyout-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Transat&#39;s board accepts Air Canada buyout offer</a></h4><ul><li>Air Canada (<a href='https://seekingalpha.com/symbol/ACDVF' title='Air Canada'>OTCQX:ACDVF</a> <font color='green'>+3.5%</font>) says Canadian tour operator Transat (<a href='https://seekingalpha.com/symbol/TRZBF' title='Transat A.T. Inc.'>OTC:TRZBF</a> <font color='green'>+1.6%</font>) <a href=\"https://www.reuters.com/article/us-transat-at-m-a-air-canada/transat-accepts-air-canadas-buyout-offer-deal-needs-shareholder-approval-idUSKCN1TS1VA\" target=\"_blank\">accepted its takeover offer</a> of C$520M (US$396) in cash, even though the price was below what another bidder offered.</li><li>Air Canada won Transat's board approval for the C$13/share deal despite a challenge from Montreal real estate developer Group Mach, which offered C$14/share.</li><li>The deal, which would leave Canada with just two main carriers offering domestic and international travel, is <a href=\"https://www.wsj.com/articles/transat-accepts-takeover-offer-from-air-canada-11561655793\" target=\"_blank\">expected to come under scrutiny</a> by government officials at the federal and provincial levels; it also requires approval by two-thirds of Transat shareholders.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474415\" data-linked=\"Transat&#39;s board accepts Air Canada buyout offer\" data-tweet=\"$ACDVF $TRZBF $WJAFF - Transat&#39;s board accepts Air Canada buyout offer https://seekingalpha.com/news/3474415-transats-board-accepts-air-canada-buyout-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3474415-transats-board-accepts-air-canada-buyout-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474404\" data-ts=\"1561661886\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474404-microcaps-mostly-among-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps mostly among tech movers</a></h4><ul><li><strong>Gainers</strong>: Pareteum Corpo(NASDAQ:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) <font color=\"green\">+18%</font>. Luokung Technology Corp. (NASDAQ:<a href='https://seekingalpha.com/symbol/LKCO' title='Luokung Technology Corp.'>LKCO</a>) <font color=\"green\">+13%</font>. So-Young International (NASDAQ:<a href='https://seekingalpha.com/symbol/SY' title='So-Young International Inc.'>SY</a>) <font color=\"green\">+13%</font>. Foresight Autonomous (NASDAQ:<a href='https://seekingalpha.com/symbol/FRSX' title='Foresight Autonomous Holdings Ltd.'>FRSX</a>) <font color=\"green\">+12%</font>. Applied Optoelectronics (NASDAQ:<a href='https://seekingalpha.com/symbol/AAOI' title='Applied Optoelectronics, Inc.'>AAOI</a>) <font color=\"green\">+12%</font>.</li> <li><strong>Losers</strong>: Riot Blockchain (NASDAQ:<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>) <font color=\"red\">-20%</font>. Pintec Technology Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/PT' title='Pintec Technology Holdings Limited'>PT</a>) <font color=\"red\">-15%</font>. Phunware (NASDAQ:<a href='https://seekingalpha.com/symbol/PHUN' title='Phunware, Inc.'>PHUN</a>) <font color=\"red\">-9%</font>. ReneSola (NYSE:<a href='https://seekingalpha.com/symbol/SOL' title='ReneSola Ltd'>SOL</a>) <font color=\"red\">-9%</font>. The9 Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/NCTY' title='The9 Limited'>NCTY</a>) <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474404\" data-linked=\"Microcaps mostly among tech movers\" data-tweet=\"$TEUM $LKCO $SY - Microcaps mostly among tech movers https://seekingalpha.com/news/3474404-microcaps-mostly-among-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3474404-microcaps-mostly-among-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474403\" data-ts=\"1561661487\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLGNF\" target=\"_blank\">DLGNF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474403-dialog-semi-gets-new-buy-rating\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dialog Semi gets new Buy rating</a></h4><ul><li>Equity research firm AlphaValue upgrades Dialog Semi (<a href='https://seekingalpha.com/symbol/DLGNF' title='Dialog Semiconductor Plc'>OTCPK:DLGNF</a>) from Reduce to Buy.</li><li>DLGNF shares are <font color=\"green\">up 1.9%</font> to $38.30.</li><li>Dialog has an Outperform average <a href=\"https://seekingalpha.com/symbol/DLGNF/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474403\" data-linked=\"Dialog Semi gets new Buy rating\" data-tweet=\"$DLGNF - Dialog Semi gets new Buy rating https://seekingalpha.com/news/3474403-dialog-semi-gets-new-buy-rating?source=tweet\" data-url=\"https://seekingalpha.com/news/3474403-dialog-semi-gets-new-buy-rating\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474400\" data-ts=\"1561661005\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBTC\" target=\"_blank\">GBTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474400-bitcoin-plunge-worsens-falls-below-11k\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitcoin plunge worsens - falls below $11K</a></h4><ul><li>The past few days' explosive gains for Bitcoin (<a href='https://seekingalpha.com/symbol/BTC-USD' title='Bitcoin USD'>BTC-USD</a>) have been about wiped away in the span of the last 18 hours. Things are volatile, but at current writing, the price has sunk to $10.9K vs. $13.8K late yesterday afternoon.</li><li><a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a> <font color=\"red\">-17.45%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3474400\" data-linked=\"Bitcoin plunge worsens - falls below $11K\" data-tweet=\"$GBTC $BTC-USD $GBTC - Bitcoin plunge worsens - falls below $11K https://seekingalpha.com/news/3474400-bitcoin-plunge-worsens-falls-below-11k?source=tweet\" data-url=\"https://seekingalpha.com/news/3474400-bitcoin-plunge-worsens-falls-below-11k\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>149&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474397\" data-ts=\"1561660257\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474397-boeing-737-max-flights-cancelled-carriers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More Boeing 737 MAX flights cancelled by carriers</a></h4><ul><li>Southwest Airlines (<a href='https://seekingalpha.com/symbol/LUV' title='Southwest Airlines Co.'>LUV</a> <font color='green'>+0.3%</font>) will not schedule Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color='red'>-1.9%</font>) 737 MAX flights <a href=\"https://www.reuters.com/article/us-ethiopia-airplane-southwest/airlines-cancel-more-boeing-737-max-flights-as-some-crash-victims-refuse-to-settle-idUSKCN1TS26Q\" target=\"_blank\">until at least Oct. 1</a>, a day after United Airlines (<a href='https://seekingalpha.com/symbol/UAL' title='United Continental Holdings, Inc.'>UAL</a> <font color='green'>+1.3%</font>) extended its cancellations into September.</li><li>Southwest, the world\u2019s largest MAX operator with 34 jets and dozens more on order, says its decision will result in ~150 daily flight cancellations out of its total peak daily schedule of 4K.</li><li>Southwest says it \"made this decision before any developments of the past few days,\" referring to the Federal Aviation Administration's warning that it uncovered a new issue that must be resolved before the plane can fly again.</li><li>Separately, the International Air Transport Association says coordinated regulatory action and agreeing on common pilot training requirements are <a href=\"https://www.wsj.com/articles/airlines-issue-call-for-regulators-to-return-boeings-max-jet-to-service-11561627434\" target=\"_blank\">necessary to restore public confidence</a> in returning the plane to service.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474397\" data-linked=\"More Boeing 737 MAX flights cancelled by carriers\" data-tweet=\"$BA $LUV $UAL - More Boeing 737 MAX flights cancelled by carriers https://seekingalpha.com/news/3474397-boeing-737-max-flights-cancelled-carriers?source=tweet\" data-url=\"https://seekingalpha.com/news/3474397-boeing-737-max-flights-cancelled-carriers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474393\" data-ts=\"1561659775\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOCU\" target=\"_blank\">DOCU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474393-docusign-invests-in-smart-contract-startup\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DocuSign invests in smart contract startup</a></h4><ul><li>DocuSign (NASDAQ:<a href='https://seekingalpha.com/symbol/DOCU' title='DocuSign, Inc.'>DOCU</a>) makes an undisclosed strategic investment in smart contract technology startup Clause. The $5.5M Series A was led by Galaxy Digital.</li><li>Earlier this year, DOCU announced the DocuSign Agreement Cloud suite, which aimed to automate and connect the entire agreement process.</li><li>DocuSign COO Scott Olrich: \"The technology being pioneered by Clause is one of the fundamental drivers here, and we\u2019re looking forward to partnering with them for the future.\"</li><li>DOCU shares are <font color=\"green\">up 2.8%</font> to $50.89 on a generally strong afternoon for tech.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474393\" data-linked=\"DocuSign invests in smart contract startup\" data-tweet=\"$DOCU - DocuSign invests in smart contract startup https://seekingalpha.com/news/3474393-docusign-invests-in-smart-contract-startup?source=tweet\" data-url=\"https://seekingalpha.com/news/3474393-docusign-invests-in-smart-contract-startup\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474384\" data-ts=\"1561658413\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474384-dawson-geophysical-and-earthstone-energy-among-energy-materials-gainers-barnwell-industries\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dawson Geophysical and Earthstone Energy among Energy/Materials gainers; Barnwell Industries and Key Energy Services among losers</a></h4><ul><li><b>Gainers: </b>Dawson Geophysical (NASDAQ:<a href='https://seekingalpha.com/symbol/DWSN' title='Dawson Geophysical Company'>DWSN</a>) <font color=\"green\">+10%</font>. Earthstone Energy (NYSE:<a href='https://seekingalpha.com/symbol/ESTE' title='Earthstone Energy, Inc.'>ESTE</a>) <font color=\"green\">+9%</font>. ION Geophysical (NYSE:<a href='https://seekingalpha.com/symbol/IO' title='ION Geophysical Corporation'>IO</a>) <font color=\"green\">+9%</font>. Sundance Energy Australia (NASDAQ:<a href='https://seekingalpha.com/symbol/SNDE' title='Sundance Energy Australia Limited'>SNDE</a>) <font color=\"green\">+8%</font>. Tronox (NYSE:<a href='https://seekingalpha.com/symbol/TROX' title='Tronox Holdings plc'>TROX</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Barnwell Industries (NYSEMKT:<a href='https://seekingalpha.com/symbol/BRN' title='Barnwell Industries, Inc.'>BRN</a>) <font color=\"red\">-19%</font>. Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"red\">-8%</font>. Westwater Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/WWR' title='Westwater Resources, Inc.'>WWR</a>) <font color=\"red\">-6%</font>. SilverCrest Metals (NYSEMKT:<a href='https://seekingalpha.com/symbol/SILV' title='SilverCrest Metals Inc.'>SILV</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474384\" data-linked=\"Dawson Geophysical and Earthstone Energy among Energy/Materials gainers; Barnwell Industries and Key Energy Services among losers\" data-tweet=\"$DWSN $ESTE $IO - Dawson Geophysical and Earthstone Energy among Energy/Materials gainers; Barnwell Industries and Key Energy Services among losers https://seekingalpha.com/news/3474384-dawson-geophysical-and-earthstone-energy-among-energy-materials-gainers-barnwell-industries?source=tweet\" data-url=\"https://seekingalpha.com/news/3474384-dawson-geophysical-and-earthstone-energy-among-energy-materials-gainers-barnwell-industries\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474497\" data-ts=\"1561658110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTEN\" target=\"_blank\">PTEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474497-slowing-demand-growth-prompts-patterson-uti-energy-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Slowing demand growth prompts Patterson-UTI Energy downgrade</a></h4><ul><li>Patterson-UTI Energy (<a href='https://seekingalpha.com/symbol/PTEN' title='Patterson-UTI Energy, Inc.'>PTEN</a> <font color=\"red\">-3.6%</font>) plummets after Wells Fargo <a href=\"https://thefly.com/thestreet/realmoney/index.php/PTENid2927041/PTEN-PattersonUTI-downgraded-to-Market-Perform-from-Outperform-at-Wells-Fargo\" target=\"_blank\">downgrades</a> shares to Market Perform from Outperform with a $13 price target, cut from $17.</li><li>Wells analyst Judson Bailey sees \"several macro factors converging\" to drive downside risk to lower 48 spending and activity next year, most notably slowing demand growth, and thinks forecast U.S. activity could oversupply the global oil market.</li><li>Also, RBC Capital cuts its PTEN price target to $21 from $28, as analyst Kurt Hallead says the company's U.S. frac operation \"<a href=\"https://thefly.com/thestreet/realmoney/index.php/PTENid2923459/PTEN-PattersonUTI-price-target-lowered-to--from--at-RBC-Capital\" target=\"_blank\">continues to be a drag</a>,\" with the market looking \"challenged and fragmented\" as 35 companies are \"gurgling\" on 8M horsepower of spare capacity.</li><li>PTEN's average <a href=\"https://seekingalpha.com/symbol/PTEN/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Outperform, while both its <a href=\"https://seekingalpha.com/symbol/PTEN/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors' Rating</a> and <a href=\"https://seekingalpha.com/symbol/PTEN/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> are Neutral.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474497\" data-linked=\"Slowing demand growth prompts Patterson-UTI Energy downgrade\" data-tweet=\"$PTEN - Slowing demand growth prompts Patterson-UTI Energy downgrade https://seekingalpha.com/news/3474497-slowing-demand-growth-prompts-patterson-uti-energy-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3474497-slowing-demand-growth-prompts-patterson-uti-energy-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474379\" data-ts=\"1561657587\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALXN\" target=\"_blank\">ALXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474379-fda-oks-alexions-soliris-for-rare-autoimmune-disorder-of-brain-and-spinal-cord\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OK&#39;s Alexion&#39;s Soliris for rare autoimmune disorder of the brain and spinal cord</a></h4><ul><li>The FDA <a href=\"https://www.prnewswire.com/news-releases/fda-approves-first-treatment-for-neuromyelitis-optica-spectrum-disorder-a-rare-autoimmune-disease-of-the-central-nervous-system-300876359.html\" target=\"_blank\">approves </a>Alexion Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/ALXN' title='Alexion Pharmaceuticals, Inc.'>ALXN</a> <font color=\"green\">+0.9%</font>) Soliris (eculizumab) for the treatment of neuromyelitis optica spectrum disorder &#40;NMOSD&#41; in adults who express an antibody called anti-aquaporin-4 (AQP4) (a biomarker for confirming the diagnosis).</li><li><a href=\"https://rarediseases.org/rare-diseases/neuromyelitis-optica/\" target=\"_blank\">NMOSD </a>is a rare autoimmune disorder of the brain and spinal cord characterized by inflammation of the spinal cord (myelitis) and optic nerve (optic neuritis). It occurs in 1-10 per 100,000 individuals worldwide.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474379\" data-linked=\"FDA OK&#39;s Alexion&#39;s Soliris for rare autoimmune disorder of the brain and spinal cord\" data-tweet=\"$ALXN - FDA OK&#39;s Alexion&#39;s Soliris for rare autoimmune disorder of the brain and spinal cord https://seekingalpha.com/news/3474379-fda-oks-alexions-soliris-for-rare-autoimmune-disorder-of-brain-and-spinal-cord?source=tweet\" data-url=\"https://seekingalpha.com/news/3474379-fda-oks-alexions-soliris-for-rare-autoimmune-disorder-of-brain-and-spinal-cord\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474378\" data-ts=\"1561657074\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSTK\" target=\"_blank\">OSTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474378-overstock-coms-tzero-launches-crypto-app\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Overstock.com&#39;s tZERO launches crypto app</a></h4><ul> <li>Overstock.com's (<a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a> <font color='red'>-0.6%</font>) tZERO says it launched a digital wallet and exchange services app through its tZERO crypto unit.</li> <li>The company says the initial release of the app will support bitcoin and ethereum purchases, two currencies that are vetted for longevity.</li><li>On Wall Street, D.A. Davidson called the development a significant milestone for tZERO.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17557813-tzero-subsidiary-launches-cryptocurrency-mobile-app\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3474378\" data-linked=\"Overstock.com&#39;s tZERO launches crypto app\" data-tweet=\"$OSTK - Overstock.com&#39;s tZERO launches crypto app https://seekingalpha.com/news/3474378-overstock-coms-tzero-launches-crypto-app?source=tweet\" data-url=\"https://seekingalpha.com/news/3474378-overstock-coms-tzero-launches-crypto-app\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474370\" data-ts=\"1561655084\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474370-cemtrex-and-hydrogenics-among-industrial-gainers-aqua-metals-only-loser\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cemtrex and Hydrogenics among industrial gainers; Aqua Metals only loser</a></h4><ul><li><b>Gainers: </b>Cemtrex (NASDAQ:<a href='https://seekingalpha.com/symbol/CETX' title='Cemtrex, Inc.'>CETX</a>) <font color=\"green\">+119%</font>. The New Home Company (NYSE:<a href='https://seekingalpha.com/symbol/NWHM' title='The New Home Company Inc.'>NWHM</a>) <font color=\"green\">+14%</font>. Cementos Pacasmayo (NYSE:<a href='https://seekingalpha.com/symbol/CPAC' title='Cementos Pacasmayo S.A.A.'>CPAC</a>) <font color=\"green\">+9%</font>. Hydrogenics (NASDAQ:<a href='https://seekingalpha.com/symbol/HYGS' title='Hydrogenics Corporation'>HYGS</a>) <font color=\"green\">+9%</font>.  Apogee Enterprises (NASDAQ:<a href='https://seekingalpha.com/symbol/APOG' title='Apogee Enterprises, Inc.'>APOG</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers: </b>Aqua Metals (NASDAQ:<a href='https://seekingalpha.com/symbol/AQMS' title='Aqua Metals, Inc.'>AQMS</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474370\" data-linked=\"Cemtrex and Hydrogenics among industrial gainers; Aqua Metals only loser\" data-tweet=\"$CETX $NWHM $CPAC - Cemtrex and Hydrogenics among industrial gainers; Aqua Metals only loser https://seekingalpha.com/news/3474370-cemtrex-and-hydrogenics-among-industrial-gainers-aqua-metals-only-loser?source=tweet\" data-url=\"https://seekingalpha.com/news/3474370-cemtrex-and-hydrogenics-among-industrial-gainers-aqua-metals-only-loser\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474368\" data-ts=\"1561654806\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474368-microcaps-mostly-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps mostly among midday movers</a></h4><ul><li><strong>Gainers: </strong>Cemtrex (NASDAQ:<a href='https://seekingalpha.com/symbol/CETX' title='Cemtrex, Inc.'>CETX</a>) <font color=\"green\">+120%</font>. The Howard Hughes (NYSE:<a href='https://seekingalpha.com/symbol/HHC' title='The Howard Hughes Corporation'>HHC</a>) <font color=\"green\">+38%</font>. J.Jill (NYSE:<a href='https://seekingalpha.com/symbol/JILL' title='J.Jill, Inc.'>JILL</a>) <font color=\"green\">+21%</font>. Foresight Autonomous Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/FRSX' title='Foresight Autonomous Holdings Ltd.'>FRSX</a>) <font color=\"green\">+21%</font>. Zogenix (NASDAQ:<a href='https://seekingalpha.com/symbol/ZGNX' title='Zogenix, Inc.'>ZGNX</a>) <font color=\"green\">+21%</font>. Herman Miller (NASDAQ:<a href='https://seekingalpha.com/symbol/MLHR' title='Herman Miller, Inc.'>MLHR</a>) <font color=\"green\">+18%</font>. Atossa Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics Inc.'>ATOS</a>) <font color=\"green\">+16%</font>.  Dova Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DOVA' title='Dova Pharmaceuticals, Inc.'>DOVA</a>) <font color=\"green\">+15%</font>. Full House Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/FLL' title='Full House Resorts, Inc.'>FLL</a>) <font color=\"green\">+15%</font>. iFresh (NASDAQ:<a href='https://seekingalpha.com/symbol/IFMK' title='iFresh Inc.'>IFMK</a>) <font color=\"green\">+14%</font>.</li> <li><strong>Losers: </strong>XpresSpa Group (NASDAQ:<a href='https://seekingalpha.com/symbol/XSPA' title='XpresSpa Group, Inc.'>XSPA</a>) <font color=\"red\">-59%</font>. Aclaris Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ACRS' title='Aclaris Therapeutics, Inc.'>ACRS</a>) <font color=\"red\">-45%</font>. Eros International (NYSE:<a href='https://seekingalpha.com/symbol/EROS' title='Eros International Plc'>EROS</a>) <font color=\"red\">-21%</font>. Barnwell Industries (NYSEMKT:<a href='https://seekingalpha.com/symbol/BRN' title='Barnwell Industries, Inc.'>BRN</a>) <font color=\"red\">-20%</font>. Zynex (NASDAQ:<a href='https://seekingalpha.com/symbol/ZYXI' title='Zynex, Inc.'>ZYXI</a>) <font color=\"red\">-19%</font>. Marathon Patent Group (NASDAQ:<a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a>) <font color=\"red\">-18%</font>. SSLJ.com (YGTY) <font color=\"red\">-17%</font>. Riot Blockchain (NASDAQ:<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>) <font color=\"red\">-17%</font>. Acer Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ACER' title='Acer Therapeutics Inc.'>ACER</a>) <font color=\"red\">-14%</font>. Oasmia Pharmaceutical AB (NASDAQ:<a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical AB &#40;publ&#41;'>OASM</a>) <font color=\"red\">-13%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474368\" data-linked=\"Microcaps mostly among midday movers\" data-tweet=\"$CETX $HHC $JILL - Microcaps mostly among midday movers https://seekingalpha.com/news/3474368-microcaps-mostly-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3474368-microcaps-mostly-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474367\" data-ts=\"1561654712\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRH\" target=\"_blank\">DRH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474367-diamondrock-hospitalityplus-3_9-wells-fargo-upgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DiamondRock Hospitality +3.9% as Wells Fargo upgrades</a></h4><ul><li>DiamondRock Hospitality (NYSE:<a href='https://seekingalpha.com/symbol/DRH' title='DiamondRock Hospitality Company'>DRH</a>) <font color=\"green\">advances 3.9%</font> after Wells Fargo analyst Jeffrey Donnelly upgrades the hotel REIT to market perform from underperform, on the hopes of stock buybacks and a brighter 2020 outlook.</li><li>Increases price target to $10.50 from $10.00.</li><li>~20% discount to NAV in the sector is putting pressure on management teams to consider buybacks, Donnelly wrote in a note.</li><li>Many of DRH's core markets, assets may shot greater RevPAR growth into 2020, he notes.</li><li>Sell-side average rating <a href=\"https://seekingalpha.com/symbol/DRH/ratings/sell-side-ratings\" target=\"_blank\">Hold </a>(2 Buy, 7 Hold, 2 Underperform, 2 Sell) previously.</li><li>In the past six months, DiamondRock <a href=\"https://seekingalpha.com/symbol/DRH/momentum/performance\" target=\"_blank\">has risen 10%</a>, lagging the S&amp;P 500's increase of 18% over the same time period.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474367\" data-linked=\"DiamondRock Hospitality +3.9% as Wells Fargo upgrades\" data-tweet=\"$DRH - DiamondRock Hospitality +3.9% as Wells Fargo upgrades https://seekingalpha.com/news/3474367-diamondrock-hospitalityplus-3_9-wells-fargo-upgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3474367-diamondrock-hospitalityplus-3_9-wells-fargo-upgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474366\" data-ts=\"1561654701\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474366-blackberry-responds-to-piece-claiming-sec-rules-violation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry responds to piece claiming SEC rules violation</a></h4><ul>   <li>BlackBerry (NYSE:<a href='https://seekingalpha.com/symbol/BB' title='BlackBerry Limited'>BB</a>) is rapidly responding to an article this hour alleging the company's violating SEC rules by using nonstandard metrics.</li>    <li>A Dow Jones <a href=\"https://www.marketwatch.com/story/blackberrys-use-of-non-standard-metrics-violates-sec-rules-2019-06-26\" target=\"_blank\">piece in MarketWatch</a> says the company's earnings report puts it at risk of an enforcement action due to a headline touting non-GAAP revenue, followed by four non-GAAP measures.</li>    <li>Companies are bound by SEC rules to lead with their GAAP numbers, the article notes.</li>    <li>In a <a href=\"https://seekingalpha.com/pr/17558306-blackberry-comments-use-non-gaap-metrics\" target=\"_blank\">statement</a>, BlackBerry says \"The information in our financial disclosures complies with U.S. securities laws that apply to us as a Canadian foreign private issuer, including all rules regarding the use of non-GAAP measures.</li>    <li>\"We believe the non-GAAP information, together with our GAAP information, provides shareholders with valuable information regarding our financial performance,\" the company continues.</li>    <li>BlackBerry shares are <font color=\"red\">down 5.2%</font> today.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474366\" data-linked=\"BlackBerry responds to piece claiming SEC rules violation\" data-tweet=\"$BB - BlackBerry responds to piece claiming SEC rules violation https://seekingalpha.com/news/3474366-blackberry-responds-to-piece-claiming-sec-rules-violation?source=tweet\" data-url=\"https://seekingalpha.com/news/3474366-blackberry-responds-to-piece-claiming-sec-rules-violation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>198&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474364\" data-ts=\"1561654643\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474364-howard-hughes-leads-financial-gainers-clipper-realty-and-cohen-company-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Howard Hughes leads financial gainers, Clipper Realty and Cohen &amp; Company among losers</a></h4><ul><li><b>Gainers:</b> The Howard Hughes (NYSE:<a href='https://seekingalpha.com/symbol/HHC' title='The Howard Hughes Corporation'>HHC</a>) <font color=\"green\">+37%</font>. OFG Bancorp (NYSE:<a href='https://seekingalpha.com/symbol/OFG' title='OFG Bancorp'>OFG</a>) <font color=\"green\">+11%</font>. Mmtec (NASDAQ:<a href='https://seekingalpha.com/symbol/MTC' title='Mmtec, Inc.'>MTC</a>) <font color=\"green\">+9%</font>. 360 Finance (NASDAQ:<a href='https://seekingalpha.com/symbol/QFIN' title='360 Finance, Inc.'>QFIN</a>) <font color=\"green\">+8%</font>. Impac Mortgage Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/IMH' title='Impac Mortgage Holdings, Inc.'>IMH</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers:</b> Cohen &amp; Company (NYSEMKT:<a href='https://seekingalpha.com/symbol/COHN' title='Cohen & Company Inc.'>COHN</a>) <font color=\"red\">-10%</font>. Clipper Realty (NYSE:<a href='https://seekingalpha.com/symbol/CLPR' title='Clipper Realty Inc.'>CLPR</a>) <font color=\"red\">-6%</font>. Oxbridge Re Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/OXBR' title='Oxbridge Re Holdings Limited'>OXBR</a>) <font color=\"red\">-5%</font>. China Internet Nationwide Financial Services (NASDAQ:<a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474364\" data-linked=\"Howard Hughes leads financial gainers, Clipper Realty and Cohen &amp; Company among losers\" data-tweet=\"$HHC $OFG $MTC - Howard Hughes leads financial gainers, Clipper Realty and Cohen &amp; Company among losers https://seekingalpha.com/news/3474364-howard-hughes-leads-financial-gainers-clipper-realty-and-cohen-company-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3474364-howard-hughes-leads-financial-gainers-clipper-realty-and-cohen-company-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474361\" data-ts=\"1561653878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBEV\" target=\"_blank\">NBEV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474361-new-age-beverage-defends-against-short-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Age Beverage defends itself against short report</a></h4><ul> <li>Shares of New Age Beverage (<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>) are having a volatile day after a report from short-selling firm Grizzly Research alleges that the company's Morinda's Chinese business could be shut down and questions its auditor.</li> <li>New Age Beverages maintains the short report is inaccurate.</li> <li>NBEV has recovered quite a bit after being down almost 5% earlier in the session.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474361\" data-linked=\"New Age Beverage defends itself against short report\" data-tweet=\"$NBEV - New Age Beverage defends itself against short report https://seekingalpha.com/news/3474361-new-age-beverage-defends-against-short-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3474361-new-age-beverage-defends-against-short-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474354\" data-ts=\"1561652686\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TALO\" target=\"_blank\">TALO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474354-talos-energys-zama-appraisal-well-results-top-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Talos Energy&#39;s Zama appraisal well results top expectations</a></h4><ul><li>Talos Energy (<a href='https://seekingalpha.com/symbol/TALO' title='Talos Energy Inc.'>TALO</a> <font color='green'>+3.3%</font>) says it <a href=\"https://seekingalpha.com/pr/17557165-talos-energy-completes-zama-appraisal-program\" target=\"_blank\">completed the appraisal</a> at its third and final appraisal well at the Zama oil discovery offshore Mexico, <a href=\"https://www.offshoreenergytoday.com/talos-done-with-zama-appraisal-fid-in-2020/\" target=\"_blank\">aimed at better defining the resource potential</a> of the discovery made in 2017.</li><li>Talos says preliminary well data matches or exceeds expectations, placing its gross recoverable resource estimate in the upper half of the pre-appraisal guidance range of 400M-800M boe.</li><li>The consortium - which includes Wintershall's Sierra Oil &amp; Gas and Premier Oil (<a href='https://seekingalpha.com/symbol/PMOIF' title='Premier Oil plc'>OTCPK:PMOIF</a>) - is advancing both its front-end  engineering and design work streams with the aim of making a final investment decision on  the project in 2020, pending required government approvals.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474354\" data-linked=\"Talos Energy&#39;s Zama appraisal well results top expectations\" data-tweet=\"$TALO $TALO $PMOIF - Talos Energy&#39;s Zama appraisal well results top expectations https://seekingalpha.com/news/3474354-talos-energys-zama-appraisal-well-results-top-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3474354-talos-energys-zama-appraisal-well-results-top-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474352\" data-ts=\"1561652471\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSS\" target=\"_blank\">TSS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474352-total-systemplus-1_1-after-hsr-early-termination-granted\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Total System +1.1% after HSR early termination granted</a></h4><ul><li>Total System Services (NYSE:<a href='https://seekingalpha.com/symbol/TSS' title='Total System Services, Inc.'>TSS</a>) <font color=\"green\">rises 1.1%</font> after the U.S. <a href=\"https://www.ftc.gov/enforcement/premerger-notification-program/early-termination-notices/20191474\" target=\"_blank\">grants HSR early termination</a> for Global Payments' (<a href='https://seekingalpha.com/symbol/GPN' title='Global Payments Inc.'>GPN</a> <font color='green'>+0.8%</font>) planned acquisition of the company.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3467038-global-payments-total-system-merge-21_5b-stock-deal\" target=\"_blank\">Global Payments, Total System to merge in $21.5B stock deal</a> (May 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3474352\" data-linked=\"Total System +1.1% after HSR early termination granted\" data-tweet=\"$TSS $TSS $GPN - Total System +1.1% after HSR early termination granted https://seekingalpha.com/news/3474352-total-systemplus-1_1-after-hsr-early-termination-granted?source=tweet\" data-url=\"https://seekingalpha.com/news/3474352-total-systemplus-1_1-after-hsr-early-termination-granted\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474351\" data-ts=\"1561652279\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACN\" target=\"_blank\">ACN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474351-accenture-bull-discusses-bookings-lumpiness\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Accenture bull discusses bookings &#39;lumpiness&#39;</a></h4><ul><li>Cowen analyst Bryan Bergin discusses Accenture's (NYSE:<a href='https://seekingalpha.com/symbol/ACN' title='Accenture plc'>ACN</a>) <a href=\"https://seekingalpha.com/news/3474194-accenture-minus-1_8-percent-despite-beats-raised-guidance\" target=\"_blank\">earnings report</a> and the bookings performance pushing shares <font color=\"red\">down 1.1%</font>.</li><li>Bergin says the bookings decrease seems to reflect \"robust 2Q bookings performance (+20% y/y CC) and the challenging comp (+15% y/y CC).\"</li><li>Cowen maintains an Outperform rating and $190 price target.</li><li>ACN has an Outperform average <a href=\"https://seekingalpha.com/symbol/ACN/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474351\" data-linked=\"Accenture bull discusses bookings &#39;lumpiness&#39;\" data-tweet=\"$ACN - Accenture bull discusses bookings &#39;lumpiness&#39; https://seekingalpha.com/news/3474351-accenture-bull-discusses-bookings-lumpiness?source=tweet\" data-url=\"https://seekingalpha.com/news/3474351-accenture-bull-discusses-bookings-lumpiness\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474346\" data-ts=\"1561651791\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRVN\" target=\"_blank\">TRVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474346-new-finance-chief-trevena-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New finance chief at Trevena; shares up 3%</a></h4><ul><li>Trevena (<a href='https://seekingalpha.com/symbol/TRVN' title='Trevena, Inc.'>TRVN</a> <font color=\"green\">+3%</font>) <a href=\"https://seekingalpha.com/pr/17557445-trevena-appoints-barry-shin-chief-financial-officer\" target=\"_blank\">appoints </a>Barry Shin at Chief Financial Officer. He joins the firm from Mizuho Securities where he was Managing Director in the Healthcare Investment Banking Group.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474346\" data-linked=\"New finance chief at Trevena; shares up 3%\" data-tweet=\"$TRVN - New finance chief at Trevena; shares up 3% https://seekingalpha.com/news/3474346-new-finance-chief-trevena-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3474346-new-finance-chief-trevena-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474343\" data-ts=\"1561651523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YNDX\" target=\"_blank\">YNDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474343-yandex-expands-ride-hailing-romania-ghana\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yandex expands ride-hailing into Romania, Ghana</a></h4><ul>   <li>Yandex.Taxi (<a href=\"http://seekingalpha.com/symbol/YNDX\" target=\"_blank\">YNDX</a> <font color=\"green\">+1.9%</font>) has moved into Romania and Ghana as its ride-hailing service continues expansion.</li>    <li>It's <a href=\"http://business-review.eu/business/auto/ride-hailing-app-yango-launches-in-bucharest-202665\" target=\"_blank\">headed into Romania</a> via its Yango brand, which operates in 16 countries across Europe, the Middle East and Africa. Rides there ordered through the app start at a discounted price of 5 Romanian leu (about $1.20), which includes 3 km and seven minutes. A ride from Otopeni Airport to the center of Bucharest would cost about 35 leu ($8.42).</li>    <li>Yango's also started operations in Ghana, which becomes the second African country with the service after the Ivory Coast.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3474343\" data-linked=\"Yandex expands ride-hailing into Romania, Ghana\" data-tweet=\"$YNDX - Yandex expands ride-hailing into Romania, Ghana https://seekingalpha.com/news/3474343-yandex-expands-ride-hailing-romania-ghana?source=tweet\" data-url=\"https://seekingalpha.com/news/3474343-yandex-expands-ride-hailing-romania-ghana\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474342\" data-ts=\"1561651511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NURO\" target=\"_blank\">NURO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474342-neurometrix-axes-11-jobs-in-cost-cutting-move-shares-down-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NeuroMetrix axes 11 jobs in cost-cutting move; shares down 3%</a></h4><ul><li>Aimed at conserving resources, NeuroMetrix (<a href='https://seekingalpha.com/symbol/NURO' title='NeuroMetrix, Inc.'>NURO</a> <font color=\"red\">-3.1%</font>) has <a href=\"https://seekingalpha.com/pr/17557437-neurometrix-provides-strategic-update\" target=\"_blank\">terminated </a>11 employees. Severance costs were ~$200K. The company has now shed over half of its headcount this year.</li><li>It also plans to sublet its corporate office and consolidate its operations at its manufacturing and fulfillment facility, a move anticipated to cost another $200K. In addition, a $2M charge will be recorded related to the write-down of excess Quell inventory.</li><li>The company has engaged Ladenburg Thalmann to advise on strategic alternatives.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474342\" data-linked=\"NeuroMetrix axes 11 jobs in cost-cutting move; shares down 3%\" data-tweet=\"$NURO - NeuroMetrix axes 11 jobs in cost-cutting move; shares down 3% https://seekingalpha.com/news/3474342-neurometrix-axes-11-jobs-in-cost-cutting-move-shares-down-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3474342-neurometrix-axes-11-jobs-in-cost-cutting-move-shares-down-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474339\" data-ts=\"1561651171\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HHC\" target=\"_blank\">HHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474339-howard-hughes-rockets-36-board-mulls-options\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Howard Hughes rockets 36% as board mulls options</a></h4><ul><li>Howard Hughes (NYSE:<a href='https://seekingalpha.com/symbol/HHC' title='The Howard Hughes Corporation'>HHC</a>) resumes trading, surging 36%, after the real estate company<a href=\"https://seekingalpha.com/pr/17558169-howard-hughes-corporation-announces-review-strategic-alternatives-maximize-shareholder-value\" target=\"_blank\"> confirms</a> that its board is exploring ways to maximize shareholder value.</li><li>The board hired Centerview Partners to help in the review; options being considered include a sale, joint venture, or spinoff of part of the company; recapitalization; changes in corporate structure; or sale of the entire company.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3474320-howard-hughes-trading-halted-record-surge-update\" target=\"_blank\">Howard Hughes trading halted after record surge (update)</a> (June 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3474339\" data-linked=\"Howard Hughes rockets 36% as board mulls options\" data-tweet=\"$HHC - Howard Hughes rockets 36% as board mulls options https://seekingalpha.com/news/3474339-howard-hughes-rockets-36-board-mulls-options?source=tweet\" data-url=\"https://seekingalpha.com/news/3474339-howard-hughes-rockets-36-board-mulls-options\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474337\" data-ts=\"1561651140\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474337-herman-miller-leads-consumer-gainers-conagra-brands-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Herman Miller leads consumer gainers; Conagra Brands leads the losers</a></h4><ul><li><b>Gainers: </b>Herman Miller (NASDAQ:<a href='https://seekingalpha.com/symbol/MLHR' title='Herman Miller, Inc.'>MLHR</a>) <font color=\"green\">+16%</font>. The Alkaline Water (NASDAQ:<a href='https://seekingalpha.com/symbol/WTER' title='The Alkaline Water Company Inc.'>WTER</a>) <font color=\"green\">+14%</font>. Delta Apparel (NYSEMKT:<a href='https://seekingalpha.com/symbol/DLA' title='Delta Apparel, Inc.'>DLA</a>) <font color=\"green\">+9%</font>. Funko (NASDAQ:<a href='https://seekingalpha.com/symbol/FNKO' title='Funko, Inc.'>FNKO</a>) <font color=\"green\">+7%</font>. Liberty TripAdvisor (NASDAQ:<a href='https://seekingalpha.com/symbol/LTRPA' title='Liberty TripAdvisor Holdings, Inc.'>LTRPA</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Conagra Brands (NYSE:<a href='https://seekingalpha.com/symbol/CAG' title='Conagra Brands, Inc.'>CAG</a>) <font color=\"red\">-13%</font>. Future FinTech Group (NASDAQ:<a href='https://seekingalpha.com/symbol/FTFT' title='Future FinTech Group Inc.'>FTFT</a>) <font color=\"red\">-7%</font>. Lifeway Foods (NASDAQ:<a href='https://seekingalpha.com/symbol/LWAY' title='Lifeway Foods, Inc.'>LWAY</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474337\" data-linked=\"Herman Miller leads consumer gainers; Conagra Brands leads the losers\" data-tweet=\"$MLHR $WTER $DLA - Herman Miller leads consumer gainers; Conagra Brands leads the losers https://seekingalpha.com/news/3474337-herman-miller-leads-consumer-gainers-conagra-brands-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3474337-herman-miller-leads-consumer-gainers-conagra-brands-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474335\" data-ts=\"1561650776\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASMB\" target=\"_blank\">ASMB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474335-dosing-underway-in-early-stage-study-of-assemblys-abi-m201-in-uc-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dosing underway in early-stage study of Assembly&#39;s ABI-M201 in UC; shares up 3%</a></h4><ul><li>The first patient has been <a href=\"https://seekingalpha.com/pr/17557454-assembly-biosciences-announces-first-patient-dosed-abi-m201-phase-1b-clinical-trial-mildly\" target=\"_blank\">dosed </a>in a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03923478?spons=assembly+biosciences&amp;rank=1\" target=\"_blank\">Phase 1b clinical trial</a> evaluating Assembly Biosciences' (<a href='https://seekingalpha.com/symbol/ASMB' title='Assembly Biosciences, Inc.'>ASMB</a> <font color=\"green\">+3.4%</font>) ABI-M201 in patients with mildly to moderately active ulcerative colitis &#40;UC&#41;.</li><li>The primary endpoint is safety. Secondary endpoints include efficacy measures. The estimated primary completion date is June 2021.</li><li>ABI-M201 is an orally administered live biotherapeutic consisting of a rationally designed consortium of certain bacteria that has demonstrated the ability to modulate UC-related cellular mechanisms.</li><li>The company is collaborating with Allergan on development.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474335\" data-linked=\"Dosing underway in early-stage study of Assembly&#39;s ABI-M201 in UC; shares up 3%\" data-tweet=\"$ASMB - Dosing underway in early-stage study of Assembly&#39;s ABI-M201 in UC; shares up 3% https://seekingalpha.com/news/3474335-dosing-underway-in-early-stage-study-of-assemblys-abi-m201-in-uc-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3474335-dosing-underway-in-early-stage-study-of-assemblys-abi-m201-in-uc-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474332\" data-ts=\"1561649988\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLRX\" target=\"_blank\">VLRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474332-valeritas-files-u-s-application-for-use-of-regular-insulin-v-go\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeritas files U.S. application for use of regular insulin with V-Go</a></h4><ul><li>Valeritas Holdings (<a href='https://seekingalpha.com/symbol/VLRX' title='Valeritas Holdings, Inc.'>VLRX</a> <font color=\"red\">-2.4%</font>) has <a href=\"https://seekingalpha.com/pr/17557424-valeritas-files-special-510-k-fda-labeling-change-include-use-regular-human-insulin-v-go\" target=\"_blank\">filed</a> a supplemental marketing application [called a Special 510(k)] with the FDA seeking clearance to use regular human insulin with its wearable V-Go device. The company says the expanded use, if approved, will save patients money.</li><li>V-Go is currently cleared for use with a U100 fast-acting insulin, like rapid-acting insulin analogs, which is more expensive.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474332\" data-linked=\"Valeritas files U.S. application for use of regular insulin with V-Go\" data-tweet=\"$VLRX - Valeritas files U.S. application for use of regular insulin with V-Go https://seekingalpha.com/news/3474332-valeritas-files-u-s-application-for-use-of-regular-insulin-v-go?source=tweet\" data-url=\"https://seekingalpha.com/news/3474332-valeritas-files-u-s-application-for-use-of-regular-insulin-v-go\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474331\" data-ts=\"1561649874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474331-casino-stocks-steady-despite-weak-nevada-numbers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Casino stocks steady despite weak Nevada numbers</a></h4><ul>          <li>Casinos in Nevada reported that gaming win revenue fell <a href=\"https://gaming.nv.gov/modules/showdocument.aspx?documentid=14638\" target=\"_blank\">5.96%</a> in May to $982M.</li>         <li>Revenue on the Las Vegas Strip was down 11.1% during the month to $517M, while downtown Las Vegas gaming win was up 2.8% to $55M. Boulder casino gaming win was up 12.6% to $70M.</li>      <li>Total slots win across the state was 1.46% higher to $680M off a win percentage of 6.9%.</li>       <li>Games and tables win fell 19.2% to $302M off a win percentage of 12.1%. Baccarat gaming dropped 55% to $55M during the month (Chinese tourism drying up?)</li>      <li>Nevada-related casino stocks are holding up pretty well following the weak print, including Caesars Entertainment (<a href='https://seekingalpha.com/symbol/CZR' title='Caesars Entertainment Corporation'>CZR</a> <font color='green'>+0.1%</font>), MGM Resorts (<a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a> <font color='green'>+0.4%</font>), Boyd Gaming (<a href='https://seekingalpha.com/symbol/BYD' title='Boyd Gaming Corporation'>BYD</a> <font color='green'>+0.4%</font>), Wynn Resorts (<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a> <font color='green'>+1%</font>), Caesars Entertainment (<a href='https://seekingalpha.com/symbol/CZR' title='Caesars Entertainment Corporation'>CZR</a> <font color='green'>+0.1%</font>), Las Vegas Sands (<a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a> <font color='red'>-0.6%</font>), Full House Resorts (<a href='https://seekingalpha.com/symbol/FLL' title='Full House Resorts, Inc.'>FLL</a> <font color='green'>+14.3%</font>) and Red Rock Resorts (<a href='https://seekingalpha.com/symbol/RRR' title='Red Rock Resorts, Inc.'>RRR</a> <font color='red'>-0.8%</font>).</li>                          <li>Related ETF: <a href='https://seekingalpha.com/symbol/BJK' title='VanEck Vectors Gaming ETF'>BJK</a></li>     </ul><div class=\"tiny-share-widget\" data-id=\"3474331\" data-linked=\"Casino stocks steady despite weak Nevada numbers\" data-tweet=\"$CZR $MGM $BYD - Casino stocks steady despite weak Nevada numbers https://seekingalpha.com/news/3474331-casino-stocks-steady-despite-weak-nevada-numbers?source=tweet\" data-url=\"https://seekingalpha.com/news/3474331-casino-stocks-steady-despite-weak-nevada-numbers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474330\" data-ts=\"1561649820\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474330-boeing-seeking-settlement-lion-air-crash-families-wsj\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing seeking settlement with Lion Air crash families - WSJ</a></h4><ul><li>Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color='red'>-2.4%</font>) is <a href=\"https://www.wsj.com/articles/boeing-looks-to-settle-lion-air-claims-11561647474\" target=\"_blank\">negotiating a proposed settlement</a> with the families of some victims of last year's crash of a Lion Air 737 MAX jetliner, <em>WSJ</em> reports, citing court filings at a hearing today in Chicago.</li><li>Boeing has provided plaintiffs' counsel with discovery documents, with any proposed settlement due to be reviewed in court at hearings scheduled to start on July 17, according to the report, which adds the parties are aiming to reach an agreement by late August.</li><li>The company faces more than 50 lawsuits related to the Lion Air crash, with more are set to be filed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474330\" data-linked=\"Boeing seeking settlement with Lion Air crash families - WSJ\" data-tweet=\"$BA - Boeing seeking settlement with Lion Air crash families - WSJ https://seekingalpha.com/news/3474330-boeing-seeking-settlement-lion-air-crash-families-wsj?source=tweet\" data-url=\"https://seekingalpha.com/news/3474330-boeing-seeking-settlement-lion-air-crash-families-wsj\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474329\" data-ts=\"1561649631\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPTH\" target=\"_blank\">LPTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474329-lightpath-technologies-receives-1_9m-order-for-bd6-infrared-optics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LightPath Technologies receives $1.9M order for BD6 infrared optics</a></h4><ul><li>LightPath Technologies (<a href='https://seekingalpha.com/symbol/LPTH' title='LightPath Technologies, Inc.'>LPTH</a> <font color=\"green\">+0.6%</font>) has been <a href=\"https://seekingalpha.com/pr/17557721-lightpath-technologies-announced-1_9-million-order-bd6-infrared-optics\" target=\"_blank\">awarded</a> a $1.9M order for 19mm and 24mm infrared lens assemblies from a North American manufacturer.</li><li>The IR optics will be manufactured from LightPath's proprietary Black Diamond\u2122 (\"BD6\") infrared material.</li><li>Lens assemblies for the contract will be produced and shipped over a 12-month period beginning July 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474329\" data-linked=\"LightPath Technologies receives $1.9M order for BD6 infrared optics\" data-tweet=\"$LPTH - LightPath Technologies receives $1.9M order for BD6 infrared optics https://seekingalpha.com/news/3474329-lightpath-technologies-receives-1_9m-order-for-bd6-infrared-optics?source=tweet\" data-url=\"https://seekingalpha.com/news/3474329-lightpath-technologies-receives-1_9m-order-for-bd6-infrared-optics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474326\" data-ts=\"1561649592\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474326-hennes-mauritz-soars-14_3-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hennes &amp; Mauritz soars 14.3% post Q2 results</a></h4><ul><li>Hennes &amp; Mauritz (<a href='https://seekingalpha.com/symbol/HNNMY' title='H & M Hennes & Mauritz AB &#40;publ&#41;'>OTCPK:HNNMY</a> <font color=\"green\">+14.3%</font>) reports <a href=\"https://hmgroup.com/content/dam/hmgroup/groupsite/documents/masterlanguage/cision/2019/06/Six-month%20report%20Q2%202019.pdf\" target=\"_blank\">Q2</a> revenues of SEK57.5B (+10.6% Y/Y) and net sales increased by 6% Y/Y, in local currencies.</li><li>Online sales in Q2 increased by 27% in SEK and in local currencies the increase was 20%.</li><li>New Business increased sales in Q2 by 21% in SEK and by 18% in local currencies.</li><li>Gross margin <font color=\"red\">declined 70 bps</font> to 55.4% and operating margin also <font color=\"red\">declined 130 bps</font> to 10.3%.</li><li>Net debt in relation to EBITDA amounted to 0.5.</li><li>Currency adjusted the stock-in-trade increased by 4% and in SEK the book value of stock-in-trade increased by 11% to SEK40.4M which 32.4% of total assets.</li><li>As customer satisfaction and sales increase, the group has intensified its transformation work even further, which had a dampening effect on earnings development.</li><li>In the H1, excluding franchise, the group opened 83 stores and closed 74 stores, i.e. a net increase of 9 new stores, which had 4,979 stores as of 31 May2019, of which 257 were operated by franchise partners.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3474252-hennes-and-mauritz-reports-q2-results\" target=\"_blank\">Hennes &amp; Mauritz reports Q2 results</a> (Jun. 27 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3474326\" data-linked=\"Hennes &amp; Mauritz soars 14.3% post Q2 results\" data-tweet=\"$HNNMY - Hennes &amp; Mauritz soars 14.3% post Q2 results https://seekingalpha.com/news/3474326-hennes-mauritz-soars-14_3-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3474326-hennes-mauritz-soars-14_3-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474327\" data-ts=\"1561649387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLCNF\" target=\"_blank\">GLCNF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474327-fatal-collapse-reported-glencore-mine-in-congo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fatal collapse reported at Glencore mine in Congo</a></h4><ul><li>Glencore (<a href='https://seekingalpha.com/symbol/GLCNF' title='Glencore plc'>OTCPK:GLCNF</a> <font color=\"red\">-6.8%</font>) dives on news that <a href=\"https://www.reuters.com/article/congo-mining-glencore/at-least-36-killed-in-collapse-at-glencore-mine-in-congo-idUSL8N23Y53X\" target=\"_blank\">at least 36 miners have died</a> in the collapse of one of the company's copper mines in the Democratic Republic of Congo.</li><li>The accident reportedly occurred in the KOV open pit mine at the Kamoto Copper Company concession, in which Glencore owns a 75% stake.</li><li>Glencore blames the deaths on widespread \"trespassing\" by ~2K \"illegal artisanal miners\" daily.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474327\" data-linked=\"Fatal collapse reported at Glencore mine in Congo\" data-tweet=\"$GLCNF $GLNCY - Fatal collapse reported at Glencore mine in Congo https://seekingalpha.com/news/3474327-fatal-collapse-reported-glencore-mine-in-congo?source=tweet\" data-url=\"https://seekingalpha.com/news/3474327-fatal-collapse-reported-glencore-mine-in-congo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474325\" data-ts=\"1561649235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474325-wedbush-bullish-on-nvidias-strong-growth-prospects\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wedbush bullish on Nvidia&#39;s &#39;strong growth prospects&#39;</a></h4><ul><li>More details on the Wedbush <a href=\"https://seekingalpha.com/news/3474111-nvidia-gains-bull\" target=\"_blank\">initiation</a> of Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) yesterday afternoon with an Outperform rating and $184 PT.</li><li>The firm cites NVDA's \"strong growth prospects in numerous attractive end markets (AI/deep learning/cloud, gaming, autonomous driving, high speed and intelligent NICs, etc.)\"</li><li>Nvidia shares are <font color=\"green\">up 1.6%</font> to $161.85.</li><li>NVDA has an Outperform average <a href=\"https://seekingalpha.com/symbol/NVDA/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474325\" data-linked=\"Wedbush bullish on Nvidia&#39;s &#39;strong growth prospects&#39;\" data-tweet=\"$NVDA - Wedbush bullish on Nvidia&#39;s &#39;strong growth prospects&#39; https://seekingalpha.com/news/3474325-wedbush-bullish-on-nvidias-strong-growth-prospects?source=tweet\" data-url=\"https://seekingalpha.com/news/3474325-wedbush-bullish-on-nvidias-strong-growth-prospects\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474324\" data-ts=\"1561649112\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474324-pareteum-bounces-9-in-pushback-against-short-attacks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pareteum bounces 9% in pushback against short attacks</a></h4><ul>   <li>Pareteum (<a href=\"http://seekingalpha.com/symbol/TEUM\" target=\"_blank\">TEUM</a> <font color=\"green\">+9%</font>) is bouncing back today after a wave of selling spurred by a pair of short-seller reports this month.</li>    <li>Since June 6, just before Aurelius Value <a href=\"https://seekingalpha.com/news/3469934-pareteum-minus-31-percent-aurelius-value-posts-short-report\" target=\"_blank\">posted its report</a> calling the stock \"completely uninvestible,\" Pareteum shares are <font color=\"red\">down 35.8%</font>. They took a new hit yesterday after Viceroy Research alleged the company appeared to <a href=\"https://seekingalpha.com/news/3474049-pareteum-minus-18_7-percent-viceroy-piles-short-reporting\" target=\"_blank\">breach U.S. sanctions against Iran</a>.</li>    <li><a href=\"https://investors.pareteum.com/home/default.aspx\" target=\"_blank\">In response today</a>, Pareteum says it \"categorically denies\" all allegations in the short reports.</li>    <li>\"While Pareteum does not publicly comment on business relationships with its customers, it is committed to compliance with all applicable laws, including U.S. sanctions against countries such as Iran,\" it says. Certain activities in Iran \"have been or are authorized\" under applicable licenses, and \"there are longstanding U.S. policies supporting communications and Internet freedom in Iran.\"</li>    <li>Meanwhile, Northland reiterated its Outperform rating in a note focused on its meetings with senior managers, customers and partners at International Telecom Week. It has a price target of $8.50, now implying 290% upside.</li>    <li>And Lake Street Capital Markets reiterated its Buy with a price target of $6.50: \"While bears have their own thoughts on Pareteum's prospects, they do not tell the whole story,\" it says, calling the current price an \"unexpected bargain for growth stock investors.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474324\" data-linked=\"Pareteum bounces 9% in pushback against short attacks\" data-tweet=\"$TEUM - Pareteum bounces 9% in pushback against short attacks https://seekingalpha.com/news/3474324-pareteum-bounces-9-in-pushback-against-short-attacks?source=tweet\" data-url=\"https://seekingalpha.com/news/3474324-pareteum-bounces-9-in-pushback-against-short-attacks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474321\" data-ts=\"1561649010\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATRS\" target=\"_blank\">ATRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474321-antares-adds-25m-in-available-debt-capital-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Antares adds $25M in available debt capital; shares up 3%</a></h4><ul><li>Antares Pharma (<a href='https://seekingalpha.com/symbol/ATRS' title='Antares Pharma, Inc.'>ATRS</a> <font color=\"green\">+2.6%</font>) has <a href=\"https://seekingalpha.com/pr/17557444-antares-pharma-announces-amendment-existing-loan-security-agreement-hercules-capital\" target=\"_blank\">amended its agreement</a> with Hercules Capital increasing its term loan limit by $25M to $50M. It drew $15M when the contract was signed and can draw up to an additional $10M effective January 1, 2020 (through September 15, 2020). It borrowed the initial $25M in June 2017.</li><li>Concurrently, it has canceled its at-the-market equity financing deal effective July 6. It has not sold any shares under the facility since March 31.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474321\" data-linked=\"Antares adds $25M in available debt capital; shares up 3%\" data-tweet=\"$ATRS - Antares adds $25M in available debt capital; shares up 3% https://seekingalpha.com/news/3474321-antares-adds-25m-in-available-debt-capital-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3474321-antares-adds-25m-in-available-debt-capital-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474320\" data-ts=\"1561648667\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HHC\" target=\"_blank\">HHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474320-howard-hughes-trading-halted-after-record-surge-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Howard Hughes trading halted after record surge (update)</a></h4><ul><li>Howard Hughes Corp. (<a href='https://seekingalpha.com/symbol/HHC' title='The Howard Hughes Corporation'>HHC</a> <font color=\"green\">+29.7%</font>) trading was halted at about 10:41 AM ET after the stock logged in its biggest gain ever, spurred by a report that the real estate company hired bankers to explore options.</li><li>About 2.56M shares have changed hands, more than 16 times its three-month average trading volume of 153,143.</li><li><strong>Update:</strong> Howard Hughes<a href=\"https://seekingalpha.com/pr/17558169-howard-hughes-corporation-announces-review-strategic-alternatives-maximize-shareholder-value\" target=\"_blank\"> confirms </a>that it's board is conducting a broad review of potential alternatives to maximize shareholder value.</li><li>Options being considered include a sale, joint venture, or spinoff of part of the company; a recapitalization; changes in the corporate structure; or a sale of the company.</li><li>\"The board and management are determined to close the significant gap between our share price and the company's underlying net asset value,\" said CEO David R. Weinreb in the statement.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3474289-howard-hughes-hires-bankers-explore-options-shares-plus-16-percent\" target=\"_blank\">Howard Hughes hires bankers to explore options; shares +16%</a> (June 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3474320\" data-linked=\"Howard Hughes trading halted after record surge (update)\" data-tweet=\"$HHC - Howard Hughes trading halted after record surge (update) https://seekingalpha.com/news/3474320-howard-hughes-trading-halted-after-record-surge-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3474320-howard-hughes-trading-halted-after-record-surge-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474319\" data-ts=\"1561648465\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRRA\" target=\"_blank\">SRRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474319-sierra-oncology-to-focus-resources-on-lead-drug-momelotinib\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sierra Oncology to focus resources on lead drug momelotinib</a></h4><ul><li>Aimed at crossing the finish line with lead drug momelotinib, in Phase 3 development for myelofibrosis, Sierra Oncology (<a href='https://seekingalpha.com/symbol/SRRA' title='Sierra Oncology, Inc.'>SRRA</a> <font color=\"red\">-1.7%</font>) will <a href=\"https://seekingalpha.com/pr/17557403-sierra-oncology-launches-campaign-exploring-non-dilutive-strategic-options-support\" target=\"_blank\">prioritize its existing resources</a> accordingly.</li><li>It remains committed to developing candidates SRA737 and SRA141, but will seek non-dilutive funding options to advance both.</li><li>At the end of March, it had $90.9M in cash and equivalents. Operations consumed $15.6M in Q1.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474319\" data-linked=\"Sierra Oncology to focus resources on lead drug momelotinib\" data-tweet=\"$SRRA - Sierra Oncology to focus resources on lead drug momelotinib https://seekingalpha.com/news/3474319-sierra-oncology-to-focus-resources-on-lead-drug-momelotinib?source=tweet\" data-url=\"https://seekingalpha.com/news/3474319-sierra-oncology-to-focus-resources-on-lead-drug-momelotinib\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474318\" data-ts=\"1561648366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SUNW\" target=\"_blank\">SUNW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474318-sunworks-announces-follow-on-order-from-cibao-meat-products\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunworks announces follow-on order from Cibao Meat Products</a></h4><ul><li>Sunworks (<a href='https://seekingalpha.com/symbol/SUNW' title='Sunworks, Inc.'>SUNW</a> <font color=\"green\">+8.9%</font>) has been <a href=\"https://seekingalpha.com/pr/17557608-sunworks-awarded-key-follow-order-customer-northeast-region\" target=\"_blank\">awarded</a> an engineering, procurement and construction contract to develop a 200kW car port solar system for Cibao Meat Products, a specialty food manufacturer based in Rockaway, New Jersey.</li><li>This project is expected to generate ~$1M in revenue, with engineering and construction expected to begin during the Q4 of 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474318\" data-linked=\"Sunworks announces follow-on order from Cibao Meat Products\" data-tweet=\"$SUNW - Sunworks announces follow-on order from Cibao Meat Products https://seekingalpha.com/news/3474318-sunworks-announces-follow-on-order-from-cibao-meat-products?source=tweet\" data-url=\"https://seekingalpha.com/news/3474318-sunworks-announces-follow-on-order-from-cibao-meat-products\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474312\" data-ts=\"1561647730\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APLS\" target=\"_blank\">APLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474312-apellis-up-4-on-advancement-of-aplminus-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apellis up 4% on advancement of APL-2</a></h4><ul><li>Apellis Pharmaceuticals (<a href='https://seekingalpha.com/symbol/APLS' title='Apellis Pharmaceuticals, Inc.'>APLS</a> <font color=\"green\">+4.4%</font>) is up on below-average volume on the heels of its <a href=\"https://seekingalpha.com/pr/17557486-apellis-pharmaceuticals-completes-enrollment-phase-3-aplminus-2-pegcetacoplan-head-head-study\" target=\"_blank\">announcement </a>that enrollment has been completed (80 subjects) in its Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT03500549\" target=\"_blank\">PEGASUS </a>study evaluating lead candidate APL-2 (pegcetacoplan), compared to Alexion's Soliris (eculizumab), in patients with paroxysmal nocturnal hemoglobinuria &#40;PNH&#41;.</li><li>About half of the participants are transfusion-dependent. Topline results should be available in December.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474312\" data-linked=\"Apellis up 4% on advancement of APL-2\" data-tweet=\"$APLS - Apellis up 4% on advancement of APL-2 https://seekingalpha.com/news/3474312-apellis-up-4-on-advancement-of-aplminus-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3474312-apellis-up-4-on-advancement-of-aplminus-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474311\" data-ts=\"1561647687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474311-atossa-genetics-leads-healthcare-gainers-zynex-and-acasti-pharma-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atossa Genetics leads healthcare gainers; Zynex and Acasti Pharma among losers</a></h4><ul><li><b>Gainers: </b>Atossa Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics Inc.'>ATOS</a>) <font color=\"green\">+28%</font>. DelMar Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DMPI' title='DelMar Pharmaceuticals, Inc.'>DMPI</a>) <font color=\"green\">+22%</font>. Zogenix (NASDAQ:<a href='https://seekingalpha.com/symbol/ZGNX' title='Zogenix, Inc.'>ZGNX</a>) <font color=\"green\">+19%</font>. Dova Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DOVA' title='Dova Pharmaceuticals, Inc.'>DOVA</a>) <font color=\"green\">+16%</font>. Axsome Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AXSM' title='Axsome Therapeutics, Inc.'>AXSM</a>) <font color=\"green\">+13%</font>.</li><li><b>Losers: </b>Aclaris Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ACRS' title='Aclaris Therapeutics, Inc.'>ACRS</a>) <font color=\"red\">-44%</font>. Zynex (NASDAQ:<a href='https://seekingalpha.com/symbol/ZYXI' title='Zynex, Inc.'>ZYXI</a>) <font color=\"red\">-24%</font>. Motus GI Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MOTS' title='Motus GI Holdings, Inc.'>MOTS</a>) <font color=\"red\">-11%</font>. Oasmia Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical AB &#40;publ&#41;'>OASM</a>) <font color=\"red\">-10%</font>. Acasti Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ACST' title='Acasti Pharma Inc.'>ACST</a>) <font color=\"red\">-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474311\" data-linked=\"Atossa Genetics leads healthcare gainers; Zynex and Acasti Pharma among losers\" data-tweet=\"$ATOS $DMPI $ZGNX - Atossa Genetics leads healthcare gainers; Zynex and Acasti Pharma among losers https://seekingalpha.com/news/3474311-atossa-genetics-leads-healthcare-gainers-zynex-and-acasti-pharma-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3474311-atossa-genetics-leads-healthcare-gainers-zynex-and-acasti-pharma-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474309\" data-ts=\"1561647024\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474309-zoomplus-4_4-on-joint-verizon-solution\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zoom +4.4% on joint Verizon solution</a></h4><ul><li>Verizon (NYSE:<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications Inc.'>VZ</a>) <a href=\"https://seekingalpha.com/pr/17557884-verizon-links-zoom-enhance-global-customers-business-communications-choices\" target=\"_blank\">teams</a> with Zoom Video Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/ZM' title='Zoom Video Communications, Inc.'>ZM</a>) to offer ZM's video-first unified communications platform to VZ's business customers as a cloud service.</li><li>All Verizon customers can use either Call-In Toll/Toll Free or Call-me numbers to access over 50 countries. Users can join a Zoom meeting through a Verizon wireless phone or Verizon VoIP for no additional charge.</li><li>The new Verizon/Zoom solution is now globally available.</li><li>Zoom shares are <font color=\"green\">up 4.4%</font> to $90.16.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474309\" data-linked=\"Zoom +4.4% on joint Verizon solution\" data-tweet=\"$VZ $ZM - Zoom +4.4% on joint Verizon solution https://seekingalpha.com/news/3474309-zoomplus-4_4-on-joint-verizon-solution?source=tweet\" data-url=\"https://seekingalpha.com/news/3474309-zoomplus-4_4-on-joint-verizon-solution\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474308\" data-ts=\"1561646713\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JILL\" target=\"_blank\">JILL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474308-j-jill-looks-to-break-out\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J. Jill looks to break out</a></h4><ul> <li>Shares of J. Jill (NYSE:<a href='https://seekingalpha.com/symbol/JILL' title='J.Jill, Inc.'>JILL</a>) are <font color=\"green\">up 15.9%</font> and crossed over $2.00 for the first time since late May in morning trading.</li> <li>The <a href=\"https://seekingalpha.com/symbol/JILL/ratings/sell-side-ratings\" target=\"_blank\">sell-side consensus rating</a> on J. Jill is Outperform, while the <a href=\"https://seekingalpha.com/symbol/JILL/ratings/quant-ratings\" target=\"_blank\">Seeking Alpha Quant Rating</a> is Very Bearish.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474308\" data-linked=\"J. Jill looks to break out\" data-tweet=\"$JILL - J. Jill looks to break out https://seekingalpha.com/news/3474308-j-jill-looks-to-break-out?source=tweet\" data-url=\"https://seekingalpha.com/news/3474308-j-jill-looks-to-break-out\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474304\" data-ts=\"1561646562\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPGN\" target=\"_blank\">OPGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474304-opgen-up-5-on-positive-acuitas-gene-panel-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OpGen up 5% on positive Acuitas Gene Panel data</a></h4><ul><li>Nano cap OpGen (<a href='https://seekingalpha.com/symbol/OPGN' title='OpGen, Inc.'>OPGN</a> <font color=\"green\">+4.9%</font>) is up on below-average volume in response to its <a href=\"https://seekingalpha.com/pr/17557477-opgen-s-acuitas-amr-gene-panel-shows-potential-reducing-total-time-targeted-therapy\" target=\"_blank\">announcement </a>of results from a study of 531 urine samples tested with its research-use-only Acuitas AMR Gene Panel designed to detect five pathogens and 47 antibiotic-resistant genes common to urinary tract infections. The data were presented at ASM Microbe.</li><li>The results showed 96% agreement with mass spectrometry with <em>E. coli</em> and 97% agreement with <em>K. pneumoniae</em>. In terms of antibiotic susceptibility, the agreements were 93% and 92%, respectively, for Acuitas Lighthouse Software predictions compared to each testing site's current method.</li><li>The total agreement by antibiotic class for both pathogens averaged 97% for aminoglycosides, 92% for fluoroquinolones and 93% for cephalosporins.</li><li>The company is currently conducting clinical trials to support a marketing application for Acuitas AMR Gene Panel test and the Acuitas Lighthouse Software for antibiotic resistance prediction direct from clinical samples and the management of antimicrobial resistance data in healthcare institutions.</li><li>In May, it filed a <a href=\"https://seekingalpha.com/news/3463469-opgen-10-percent-premarket-u-s-application-molecular-test\" target=\"_blank\">510(k) application</a> with the FDA for the Acuitas AMR Gene Panel test for the detection of antimicrobial resistance genes in bacterial isolates.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474304\" data-linked=\"OpGen up 5% on positive Acuitas Gene Panel data\" data-tweet=\"$OPGN - OpGen up 5% on positive Acuitas Gene Panel data https://seekingalpha.com/news/3474304-opgen-up-5-on-positive-acuitas-gene-panel-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3474304-opgen-up-5-on-positive-acuitas-gene-panel-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474303\" data-ts=\"1561646428\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DXC\" target=\"_blank\">DXC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474303-dxc-zafin-team-for-banking-solutions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DXC, Zafin team for banking solutions</a></h4><ul><li>DXC (NYSE:<a href='https://seekingalpha.com/symbol/DXC' title='DXC Technology Company'>DXC</a>) and Zafin <a href=\"https://seekingalpha.com/pr/17557867-dxc-technology-zafin-partner-help-banks-manage-conduct-risk-increase-customer-lifetime-value\" target=\"_blank\">partner</a> to create a standardized data connector between Zafin's cloud-based pricing and product control platform and DXC's core banking solutions.</li><li>The launch will externalize product and pricing control from the Hogan and Celeriti Digital Banking-as-a-Service solutions to let customers quickly adjust their approach with low costs and reduced operational risk.</li><li>DXC shares are <font color=\"green\">up 1%</font> to $54.19.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474303\" data-linked=\"DXC, Zafin team for banking solutions\" data-tweet=\"$DXC - DXC, Zafin team for banking solutions https://seekingalpha.com/news/3474303-dxc-zafin-team-for-banking-solutions?source=tweet\" data-url=\"https://seekingalpha.com/news/3474303-dxc-zafin-team-for-banking-solutions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474299\" data-ts=\"1561645827\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474299-natural-gas-inventory-builds-slightly-less-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas inventory builds slightly less than consensus</a></h4><ul><li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory:</a> <strong>+98 Bcf</strong> vs. +101 Bcf consensus, +115 Bcf last week.</li><li>Futures <font color=\"green\">+1.41%</font> to $2.300.</li><li>ETFs:<a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3474299\" data-linked=\"Natural gas inventory builds slightly less than consensus\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas inventory builds slightly less than consensus https://seekingalpha.com/news/3474299-natural-gas-inventory-builds-slightly-less-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3474299-natural-gas-inventory-builds-slightly-less-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474298\" data-ts=\"1561645738\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474298-shaw-communicationsminus-3-post-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shaw Communications -3% post Q3 results</a></h4><ul><li>Shaw Communications (<a href='https://seekingalpha.com/symbol/SJR' title='Shaw Communications Inc.'>SJR</a> <font color=\"red\">-3%</font>) reports <a href=\"https://seekingalpha.com/pr/17557716-shaw-announces-third-quarter-year-date-fiscal-2019-results\" target=\"_blank\">Q3</a> revenues of C$1.32B (+2.3% Y/Y).</li><li>Wireless service revenue increased by 22% Y/Y to C$178M over the comparable period due to the growing penetration of Big Gig data plans.</li><li>Wireless equipment revenue decreased by 9% Y/Y to C$73M as a higher proportion of customers elected the Bring Your Own Device option.</li><li>ABPU grew ~6.2% Y/Y to C$42.30 and Wireless ARPU grew 2.2% Y/Y to C$38.36.</li><li>Operating margin before restructuring costs and amortization <font color=\"red\">declined 170 bps</font> to 40%.</li><li>The Company continues to focus on improving its customer experience through the deployment of 700 MHz spectrum, resulting in an 18 bps reduction Y/Y in postpaid customer churn to a record low 1.18%.</li><li>Strong Wireless results with ~62K total net additions and record low postpaid churn as the Company deploys spectrum and network into new markets.</li><li>Also, acquired 600 MHz spectrum for a total price of C$492M, or C$0.78 per MHz-Pop, that will be used to improve existing LTE service and lay the foundation for 5G.</li><li>The company completed the sale of 80.6M Class B non-voting participating shares of Corus Entertainment for net proceeds of ~C$526M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3474237-shaw-communications-eps-beats-c-0_12-misses-revenue\" target=\"_blank\">Shaw Communications EPS beats by C$0.12, misses on revenue</a> (Jun. 27 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3474298\" data-linked=\"Shaw Communications -3% post Q3 results\" data-tweet=\"$SJR - Shaw Communications -3% post Q3 results https://seekingalpha.com/news/3474298-shaw-communicationsminus-3-post-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3474298-shaw-communicationsminus-3-post-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474293\" data-ts=\"1561645023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APOG\" target=\"_blank\">APOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474293-apogee-enterprisesplus-11-on-q1-earnings-beats-reaffirms-fy20-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apogee Enterprises +11% on Q1 earnings beats; reaffirms FY20 guidance</a></h4><ul><li>Apogee Enterprises (<a href='https://seekingalpha.com/symbol/APOG' title='Apogee Enterprises, Inc.'>APOG</a> <font color=\"green\">+11%</font>) reported Q1 revenue growth of 5.6% Y/Y to $355.4M. Sales by segments: Architectural Framing Systems $180.52M (+1% Y/Y); Architectural Glass $100.29M (+30% Y/Y); Architectural Services $65.15M (-8% Y/Y); and Large-Scale Optical $21.56M (+2% Y/Y).</li><li>Q1 Gross margin <font color=\"red\">declined by 120 bps</font> to 22.8%; and operating margin <font color=\"red\">declined slightly by 5 bps</font> to 6.5%.</li><li>Adj. EBITDA was $34.14M (-3.8% Y/Y); and margin <font color=\"red\">declined by 93 bps</font> to 9.6%.</li><li>SG&amp;A expenses were $57.93M (-1.4% Y/Y); and as percentage of revenue 16.3% down by 115 bps.</li><li>Net cash used by operating activities for the quarter was $9.74M, compared to cash provided $25.34M a year ago.</li><li>Architectural Framing Systems backlog was at $407M (-0.5% Y/Y); and Architectural Services backlog was at $483M (+8.8% Y/Y).</li><li>Company has Cash, cash equivalents and restricted cash of $28.96M as of June 1, 2019.</li><li><strong>FY20 Guidance, reaffirmed:</strong> Revenue growth 1% to 3%; operating margin 8.2% to 8.6%; EPS $3 to $3.2; tax rate of ~24.5%; and capex of $60M to $65M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3473796-apogee-declares-0_175-dividend\" target=\"_blank\">Apogee declares $0.175 dividend</a> (June 26)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3474174-apogee-eps-beats-0_03-beats-revenue\" target=\"_blank\">Apogee EPS beats by $0.03, beats on revenue</a> (June 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3474293\" data-linked=\"Apogee Enterprises +11% on Q1 earnings beats; reaffirms FY20 guidance\" data-tweet=\"$APOG - Apogee Enterprises +11% on Q1 earnings beats; reaffirms FY20 guidance https://seekingalpha.com/news/3474293-apogee-enterprisesplus-11-on-q1-earnings-beats-reaffirms-fy20-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3474293-apogee-enterprisesplus-11-on-q1-earnings-beats-reaffirms-fy20-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474296\" data-ts=\"1561644953\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADXS\" target=\"_blank\">ADXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474296-advaxis-bails-on-late-stage-study-of-axal-in-cervical-cancer-shares-down-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Advaxis bails on late-stage study of AXAL in cervical cancer; shares down 4%</a></h4><ul><li>Citing a sharpened focus on neoantigen-directed immunotherapies, Advaxis (<a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis, Inc.'>ADXS</a> <font color=\"red\">-4.4%</font>) <a href=\"https://seekingalpha.com/pr/17557378-advaxis-announces-increasing-focus-neoantigen-directed-immunotherapies-closing-phase-3\" target=\"_blank\">announces </a>that it will terminate its Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02853604?spons=advaxis&amp;phase=2&amp;rank=1\" target=\"_blank\">AIM2CERV </a>trial evaluating axalimogene filolisbac &#40;AXAL&#41; in patients with high-risk locally advanced cervical cancer, adding that it will continue to support its clinical development in other HPV-related cancers.</li><li>The company also cited the cost ($80M - 90M) and time (at least three years for initial efficacy data) required to complete the study.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474296\" data-linked=\"Advaxis bails on late-stage study of AXAL in cervical cancer; shares down 4%\" data-tweet=\"$ADXS - Advaxis bails on late-stage study of AXAL in cervical cancer; shares down 4% https://seekingalpha.com/news/3474296-advaxis-bails-on-late-stage-study-of-axal-in-cervical-cancer-shares-down-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3474296-advaxis-bails-on-late-stage-study-of-axal-in-cervical-cancer-shares-down-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474292\" data-ts=\"1561644675\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZS\" target=\"_blank\">ZS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474292-wedbush-boosts-zscaler-on-product-momentum-zsplus-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wedbush boosts Zscaler on product momentum; ZS +2%</a></h4><ul><li>Wedbush raises its Zscaler (NASDAQ:<a href='https://seekingalpha.com/symbol/ZS' title='Zscaler, Inc.'>ZS</a>) target from $82 to $87 and maintains an Outperform rating.</li><li>Analyst Daniel Ives cites internal checks showing \"growing momentum for the company\u2019s product portfolio\" in the next 12 to 18 months.</li><li>Zscaler shares are <font color=\"green\">up 2.3%</font> to $75.97.</li><li>ZS has an Outperform <a href=\"https://seekingalpha.com/symbol/ZS/ratings/sell-side-ratings\" target=\"_blank\">average Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474292\" data-linked=\"Wedbush boosts Zscaler on product momentum; ZS +2%\" data-tweet=\"$ZS - Wedbush boosts Zscaler on product momentum; ZS +2% https://seekingalpha.com/news/3474292-wedbush-boosts-zscaler-on-product-momentum-zsplus-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3474292-wedbush-boosts-zscaler-on-product-momentum-zsplus-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474291\" data-ts=\"1561644491\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BASFY\" target=\"_blank\">BASFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474291-basf-to-cut-6k-jobs-in-cost-saving-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BASF to cut 6K jobs in cost saving plan</a></h4><ul><li>In an \"organization realignment\" intended to simplify the company's structure and streamline administration, BASF (<a href='https://seekingalpha.com/symbol/BASFY' title='BASF SE'>OTCQX:BASFY</a> <font color=\"green\">+2.2%</font>) says it <a href=\"https://www.washingtonpost.com/business/chemical-company-basf-to-drop-6000-jobs-in-realignment/2019/06/27/9f994700-98e2-11e9-9a16-dc551ea5a43b_story.html\" target=\"_blank\">plans to drop 6,000 jobs by the end of 2021</a>.</li><li>The company expects the restructuring, which cuts ~5% of its global workforce, will save \u20ac300M ($340M) as part of  an ongoing efficiency program that should add \u20ac2B to annual earnings from 2021 onward.</li><li>The company reported having 122,400 employees in 2018, with 75K in Europe and 20K in North America.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474291\" data-linked=\"BASF to cut 6K jobs in cost saving plan\" data-tweet=\"$BASFY - BASF to cut 6K jobs in cost saving plan https://seekingalpha.com/news/3474291-basf-to-cut-6k-jobs-in-cost-saving-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3474291-basf-to-cut-6k-jobs-in-cost-saving-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474289\" data-ts=\"1561643885\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HHC\" target=\"_blank\">HHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474289-howard-hughes-hires-bankers-to-explore-options-sharesplus-16\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Howard Hughes hires bankers to explore options; shares +16%</a></h4><ul><li>Howard Hughes Corp. (NYSE:<a href='https://seekingalpha.com/symbol/HHC' title='The Howard Hughes Corporation'>HHC</a>) <font color=\"green\">soars 16%</font> after CNBC reports that the company<a href=\"https://www.cnbc.com/2019/06/27/david-faber-howard-hughes-corp-hires-centerview-to-explore-sale.html\" target=\"_blank\"> has hired </a>bankers Centerview Partners to explore alternatives including a possible sale of the company.</li><li>Attributes people familiar with the situation.</li><li>Bankers are also exploring joint ventures or spinoffs.</li><li>Aims to finish the review process by the end of the summer.</li><li>People familiar with the board's thinking say it's not clear if the business is well-suited as a publicly traded company; it's not a REIT like most other real estate companies and has a diverse collection of assets that doesn't lend itself to recurring and predictable cash flows real estate investors may be looking for, CNBC reports.</li><li>HHC <a href=\"https://seekingalpha.com/symbol/HHC/momentum/performance\" target=\"_blank\">has fallen 2.2%</a> in the past six months vs. an 18% increase for the S&amp;P 500.</li><li>Potential buyers may include Blackstone Group (<a href='https://seekingalpha.com/symbol/BX' title='The Blackstone Group L.P.'>BX</a> <font color='green'>+0.5%</font>) or Brookfield Property Partners (<a href='https://seekingalpha.com/symbol/BPY' title='Brookfield Property Partners L.P.'>BPY</a> <font color='green'>+0.7%</font>), but may also include large family offices or sovereign wealth funds.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474289\" data-linked=\"Howard Hughes hires bankers to explore options; shares +16%\" data-tweet=\"$HHC $BX $BPY - Howard Hughes hires bankers to explore options; shares +16% https://seekingalpha.com/news/3474289-howard-hughes-hires-bankers-to-explore-options-sharesplus-16?source=tweet\" data-url=\"https://seekingalpha.com/news/3474289-howard-hughes-hires-bankers-to-explore-options-sharesplus-16\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474288\" data-ts=\"1561643826\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRVL\" target=\"_blank\">MRVL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474288-marvellplus-2-on-target-boost-for-5g-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marvell +2% on target boost for 5G potential</a></h4><ul><li>Cowen maintains an Outperform rating and raises its Marvell (NASDAQ:<a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group Ltd.'>MRVL</a>) target from $26 to $28.</li><li>Analyst Karl Ackerman says MRVL \"remains one of the most levered plays in semis to 5G network infrastructure\" and sees 5G as the single-largest revenue driver over the next three years, potentially contributing 500bps to the annual growth.</li><li>Marvell shares are <font color=\"green\">up 2.4%</font> to $24.28.</li><li>MRVL has an Outperform <a href=\"https://seekingalpha.com/symbol/MRVL/ratings/sell-side-ratings\" target=\"_blank\">average Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474288\" data-linked=\"Marvell +2% on target boost for 5G potential\" data-tweet=\"$MRVL - Marvell +2% on target boost for 5G potential https://seekingalpha.com/news/3474288-marvellplus-2-on-target-boost-for-5g-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/3474288-marvellplus-2-on-target-boost-for-5g-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474278\" data-ts=\"1561643057\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474278-ibm-red-hat-gets-eu-approval\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBM-Red Hat gets EU approval</a></h4><ul><li>The European Union gives IBM's (<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a> <font color='green'>+0.3%</font>) acquisition of Red Hat (<a href='https://seekingalpha.com/symbol/RHT' title='Red Hat, Inc.'>RHT</a> <font color='green'>+0.7%</font>) an unconditional approval, according to Bloomberg.</li><li>The EU saw no problems with the overlapping markets and says there is significant competition from others.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474278\" data-linked=\"IBM-Red Hat gets EU approval\" data-tweet=\"$IBM $RHT - IBM-Red Hat gets EU approval https://seekingalpha.com/news/3474278-ibm-red-hat-gets-eu-approval?source=tweet\" data-url=\"https://seekingalpha.com/news/3474278-ibm-red-hat-gets-eu-approval\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474275\" data-ts=\"1561642742\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVAX\" target=\"_blank\">NVAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474275-novavax-to-sell-manufacturing-assets-to-catalent-for-18m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novavax to sell manufacturing assets to Catalent for $18M</a></h4><ul><li>Aimed at cutting operating costs while it advances NanoFlu and ResVax, Novavax (<a href='https://seekingalpha.com/symbol/NVAX' title='Novavax, Inc.'>NVAX</a> <font color=\"green\">+26.9%</font>) has <a href=\"https://seekingalpha.com/pr/17557384-novavax-catalent-biologics-enter-strategic-partnership-allowing-catalent-biologics-expand\" target=\"_blank\">agreed to sell</a> certain manufacturing assets to Catalent Biologics' (<a href='https://seekingalpha.com/symbol/CTLT' title='Catalent, Inc.'>CTLT</a>) Paragon Gene Therapy unit for $18M in cash.</li><li>Paragon will also assume the leases on two NVAX product development and manufacturing facilities and will absorb over 100 NVAX employees.</li><li>The transactions should close next month.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474275\" data-linked=\"Novavax to sell manufacturing assets to Catalent for $18M\" data-tweet=\"$NVAX $CTLT - Novavax to sell manufacturing assets to Catalent for $18M https://seekingalpha.com/news/3474275-novavax-to-sell-manufacturing-assets-to-catalent-for-18m?source=tweet\" data-url=\"https://seekingalpha.com/news/3474275-novavax-to-sell-manufacturing-assets-to-catalent-for-18m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474270\" data-ts=\"1561642196\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474270-ringcentralplus-2_1-baird-adds-to-fresh-pick-list\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RingCentral +2.1% as Baird adds to Fresh Pick list</a></h4><ul>   <li>RingCentral (NYSE:<a href='https://seekingalpha.com/symbol/RNG' title='RingCentral, Inc.'>RNG</a>) is <font color=\"green\">up 2.1%</font> premarket after an add to Baird's Fresh Pick list.</li>    <li>The firm reiterated a $135 price target -- a target raised a few times this spring from a $100 target in the winter. The $135 implies 21.7% upside.</li>   <li>Sell-side analysts <a href=\"https://seekingalpha.com/symbol/RNG/ratings/sell-side-ratings\" target=\"_blank\">rate it Buy on average</a>, while <a href=\"https://seekingalpha.com/symbol/RNG/ratings/author-ratings\" target=\"_blank\">Seeking Alpha authors are Bullish</a> and it has a <a href=\"https://seekingalpha.com/symbol/RNG/ratings/quant-ratings\" target=\"_blank\">Quant Rating of Neutral</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474270\" data-linked=\"RingCentral +2.1% as Baird adds to Fresh Pick list\" data-tweet=\"$RNG - RingCentral +2.1% as Baird adds to Fresh Pick list https://seekingalpha.com/news/3474270-ringcentralplus-2_1-baird-adds-to-fresh-pick-list?source=tweet\" data-url=\"https://seekingalpha.com/news/3474270-ringcentralplus-2_1-baird-adds-to-fresh-pick-list\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474269\" data-ts=\"1561642188\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVAX\" target=\"_blank\">NVAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474269-novavax-up-10-premarket-on-accelerated-approval-pathway-in-u-s-for-nanoflu\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novavax up 10% premarket on accelerated approval pathway in U.S. for NanoFlu</a></h4><ul><li>Novavax (NASDAQ:<a href='https://seekingalpha.com/symbol/NVAX' title='Novavax, Inc.'>NVAX</a>) is up <font color=\"green\">10%</font> premarket on increased volume on the heels of its <a href=\"https://seekingalpha.com/pr/17557443-novavax-confirms-accelerated-approval-pathway-available-licensure-nanoflu\" target=\"_blank\">announcement </a>that the FDA is on board with accelerated review status for flu vaccine NanoFlu.</li><li>The company plans to launch a Phase 3 study this fall with topline results expected in Q1 2020. If all goes well, a marketing application will follow.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474269\" data-linked=\"Novavax up 10% premarket on accelerated approval pathway in U.S. for NanoFlu\" data-tweet=\"$NVAX - Novavax up 10% premarket on accelerated approval pathway in U.S. for NanoFlu https://seekingalpha.com/news/3474269-novavax-up-10-premarket-on-accelerated-approval-pathway-in-u-s-for-nanoflu?source=tweet\" data-url=\"https://seekingalpha.com/news/3474269-novavax-up-10-premarket-on-accelerated-approval-pathway-in-u-s-for-nanoflu\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474266\" data-ts=\"1561641938\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OFG\" target=\"_blank\">OFG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474266-ofg-bancorp-jumps-17-on-transformational-deal-scotiabank\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OFG Bancorp jumps 17% on `transformational&#39; deal with Scotiabank</a></h4><ul><li>OFG Bancorp (NYSE:<a href='https://seekingalpha.com/symbol/OFG' title='OFG Bancorp'>OFG</a>)<font color=\"green\"> surges 17%</font> in premarket trading after announcing an <a href=\"https://seekingalpha.com/news/3474085-ofg-bancorp-buy-scotiabanks-puerto-rico-operations-usvi-branches\" target=\"_blank\">agreement to buy</a> Bank of Nova Scotia's (NYSE:<a href='https://seekingalpha.com/symbol/BNS' title='The Bank of Nova Scotia'>BNS</a>) Puerto Rico operations and U.S. Virgin Island branches, a deal that KBW analyst Glen Manna calls the deal \"transformational: and \"highly accretive\" for OFG.</li><li>Puts OFG in \"an excellent position to capitalize on the post-hurricane recovery\" in Puerto Rico and to address its \"nagging funding/scale issue.\"</li><li>Meanwhile, Credit Suisse analyst Mike Rizvanovic says the dealhas a \"minimal\" effect on Scotiabank, estimating that Puerto Rico accounts for ~0.5% of Scotia's consolidated earnings and was a \"very low ROE\" business.</li><li>Sees BNS repositioning its international operations, focusing on Pacific Alliance countries of Mexico, Chile, Peru, and Colombia as a positive.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474266\" data-linked=\"OFG Bancorp jumps 17% on `transformational&#39; deal with Scotiabank\" data-tweet=\"$OFG $BNS - OFG Bancorp jumps 17% on `transformational&#39; deal with Scotiabank https://seekingalpha.com/news/3474266-ofg-bancorp-jumps-17-on-transformational-deal-scotiabank?source=tweet\" data-url=\"https://seekingalpha.com/news/3474266-ofg-bancorp-jumps-17-on-transformational-deal-scotiabank\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474264\" data-ts=\"1561641796\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JWN\" target=\"_blank\">JWN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474264-nordstrom-retreats-after-goldman-sachs-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nordstrom retreats after Goldman Sachs downgrade</a></h4><ul> <li>Goldman Sachs takes Nordstrom (NYSE:<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom, Inc.'>JWN</a>) down to a Sell rating from Neutral and sets a price target of $30 off lower EPS estimates.</li> <li>\"Ongoing comp headwinds in full line and off price stores are compounded in FY19 by EBIT headwinds from ongoing strategic investments and the opening of the company's 7-floor flagship in NYC,\" warns GS.</li> <li>While the Quant Rating on Nordstrom is also flashing<a href=\"https://seekingalpha.com/symbol/JWN/ratings/quant-ratings\" target=\"_blank\"> Very Bearish</a>, SA authors are collectively  <a href=\"https://seekingalpha.com/symbol/JWN/ratings/author-ratings#filter=all\" target=\"_blank\">Bullish</a> on the department store stock.</li> <li>Shares of Nordstrom are <font color=\"red\">down 1.55%</font> premarket to $31.70.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474264\" data-linked=\"Nordstrom retreats after Goldman Sachs downgrade\" data-tweet=\"$JWN - Nordstrom retreats after Goldman Sachs downgrade https://seekingalpha.com/news/3474264-nordstrom-retreats-after-goldman-sachs-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3474264-nordstrom-retreats-after-goldman-sachs-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474263\" data-ts=\"1561641693\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATOS\" target=\"_blank\">ATOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474263-atossas-topical-endoxifen-shows-positive-action-in-mid-stage-study-shares-up-29-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atossa&#39;s topical endoxifen shows positive action in mid-stage study; shares up 29% premarket</a></h4><ul><li>Nano cap Atossa Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics Inc.'>ATOS</a>) is up <font color=\"green\">29%</font> premarket on robust volume in reaction to <a href=\"https://seekingalpha.com/pr/17557607-atossa-genetics-preliminary-phase-2-study-achieves-primary-endpoint-topical-endoxifen-rapidly\" target=\"_blank\">positive results</a> from a 90-subject Phase 2 clinical trial assessing daily 20 mg doses of topical Z Endoxifen on mammographic breast density &#40;MBD&#41;.</li><li>The primary objective was to determine the change in breast density after treatment with topical Endoxifen for up to six months aimed at informing the optimal sample size for a Phase 3 trial.</li><li>MBD was reduced by an average of 14.3% in the treatment group compared to placebo (p=0.02). About 70% of patients receiving the 20 mg dose experienced reductions in MBD.</li><li>The company says the safety profile was similar to control but 72 participants developed skin rashes and local irritation and did not complete the full six months of dosing.</li><li>Atossa believes that the ultimate value proposition of topical Exdoxifen is reducing the number of women who may develop estrogen-dependent breast cancer.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474263\" data-linked=\"Atossa&#39;s topical endoxifen shows positive action in mid-stage study; shares up 29% premarket\" data-tweet=\"$ATOS - Atossa&#39;s topical endoxifen shows positive action in mid-stage study; shares up 29% premarket https://seekingalpha.com/news/3474263-atossas-topical-endoxifen-shows-positive-action-in-mid-stage-study-shares-up-29-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3474263-atossas-topical-endoxifen-shows-positive-action-in-mid-stage-study-shares-up-29-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}